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Summary in Icelandic
Markviss meðferð (e. goal-directed therapy) með vökva og samdráttarhvetjandi lyfjum getur 
fækkað fylgikvillum og aukið lífslíkur í kjölfar stórra skurðaðgerða með því að hjálpa líka-
manum að mæta aukinni súrefnisþörf við slíkar aðstæður. Meðferðinni er yfirleitt stýrt 
með tækjum sem mæla hjartaútfall (e.cardiac output), sem er blóðmagnið sem hjartað dælir 
á hverri mínútu. Þýski lífeðlisfræðingurinn Adolf Fick lýsti fyrstur aðferð til mæla útfall 
hjartans árið 1870, en ekki var hægt að gera það hjá sjúklingum fyrr en árið 1940. Aðferðin 
þóaðist og á áttunda áratug nítjándu aldar var lungnaslagæðaleggurinn (e. pulmonary artery 
catheter - PAC) tekinn í notkun sem gat gefið  nákvæmar upplýsingar um starfsemi hjar-
tans og blóðrásarkerfisins. Ekki hefur verið sýnt fram á ávinning af notkun hans og hætta á 
alvarlegum fylgikvillum er mikil. Á síðustu árum hafa komið fram fjölmargar nýjar aðferðir 
sem eru einfaldari í notkun og áhættuminni en PAC, en hafa verið gagnrýndar fyrir að vera 
ónákvæmar við aðstæður þegar mest á reynir, kostnaðarsamar og takmörkunum háðar. Það 
er því mikil eftirspurn eftir nákvæmri og einfaldri aðferð til að stýra meðferð markvisst við 
erfiðar aðstæður, án allra aukahluta eða ífarandi inngripa svo að áhætta fyrir sjúkling verði 
sem minnst og fylgikvillar í kjölfar stórra aðgerða mögulega færri.   
Árið 1980 komu Gedeon og félagar fram með byltingarkennda hugmynd um aðferð til að 
áætla hjartaútfall til lungna út frá mælingum á koltvísýrlingi í útöndunarlofti. Hjartaútfall til 
lungna sem samsvarar hjartaútfalli um meginslagæð líkamans þegar framhjá-flæði (e. shunted 
flow) er lítið. 
Aðferðin, sem er án allra ífarandi inngripa, þróaðist með hléum en ekki tókst að gera hana 
nógu stöðuga til að mæla hjartaútfallið samfellt frá einum andardrætti til hins næsta fyrr en 
árið 2014. Kapnódýnamíska aðferðin (e. capnodynamic method), eins og hún kallast, krefst 
þess að sjúklingurinn sé sofandi og tengdur við öndunarvél sem stjórnar önduninni alfarið. 
Með því að lengja útöndunartímann í þremur af hverjum níu andardráttum er hægt að breyta 
styrk koltvísýrings í útöndunarlofti milli andardrátta og reikna blóðflæðið till lugnanna (e. 
effective pulmonary blood flow - EPBF). Það er gert með sjálfvirkri bestun á minnstu fervikum 
(e. least square error optimization) þegar níu stærðfræðijöfnum (ein fyrir hvern andardrátt) 
er raðað saman. 
Markmið þessarar doktorsritgerðar var að bera saman kapnódýnamísku aðferðina við 
nákvæmar viðmiðunaraðferðir í krefjandi aðstæðum sem geta komið upp í skurðaðgerðum. 
Í fyrstu þremur rannsóknunum, sem allar eru tilraunir á stórum grísum, bárum við kap-
nódýnamísku aðferðina saman við flæðismæli sem umlykur lugnaslagæðina og mælir 
nákvæmlega hjartaútfall. Í þessum tilraunum var aðferðin prófuð við margbreytilegar 
aðstæður, til dæmis við skyndilega breytingu á blóðflæði til hjartans, inngjöf samdráttarhvet-
jandi lyfja, stóra blæðingu, endurflæði (e. reperfusion), öndunarbilun og margar mismunandi 
stillingar á öndunarvélinni. Í fjórðu og síðustu rannsókninni var kapnódýnamíska aðferðin 
notuð í fyrsta skipti á 35 sjúklingum sem gengust undir stórar kviðarholsaðgerðir og borin 
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saman við nákvæma viðmiðunaraðferð (transpulmonary thermodilution) sem krefst æðaleg-
gja í stóra bláæð og slagæð.
Í þessum rannsóknum reyndist kapnódýnamíska aðferðin nákvæm og áreiðanleg við 
margbreytilegar aðstæður hjá grísum og mönnum og fylgdi vel breytingum (e. trending) á 
hjartaútfalli.
Við mikið endurflæði, sem oft á sér stað í stórum æðaskurðaðgerðum, varð tímabundin 
truflun á mælingum sem endurstilltist innan 5 mínútna. Við öndunarbilun eftir lungnaskaða 
minnkaði nákvæmnin, eins og við var að búast, en fylgnin við breytingar á hjartaútfalli hélst 
nokkurn veginn óbreytt miðað við hefðbundnar aðstæður í heilbrigðum lungum. Í klínísku 
rannsókninni var nákvæmnin góð og kapnódýnamíska aðferðin fylgdi vel breytingum á hjar-
taútfalli, t.d. þegar gefinn var vökvi í æð, samdráttarhvetjandi lyf notuð, eða öndunarþrýstin-
gur aukinn. 
Kapnódýnamíska gæti reynst öruggur og ódýr valkostur þegar stýra á flókinni meðferð við 
erfiðar aðstæður í umfangsmiklum skurðaðgerðum í framtíðinni. Áframhaldandi rannsóknir 
munu vonandi leiða í ljós hvort það leiði til ávinnings fyrir sjúklinga.
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Abstract
Cardiac output (CO) monitoring is ideal for guiding fluid, vasopressor and inotropic therapy 
for sufficient oxygen delivery and may improve outcome in high risk surgery. In this context, 
many minimally-and non-invasive methods have emerged during recent years, however, they 
appear less reliable when compared to the thermodilution methods during rapid changes in 
vascular volume and resistance, a common feature during major surgery. 
The capnodynamic method calculates non-shunted cardiac output, the effective pulmonary 
blood flow (COEPBF), on the basis of a capnodynamic equation describing the mole balance 
of CO2 transported to and from the lungs. By prolonging three out of every nine breaths in 
mechanically ventilated patients, COEPBF is automatically and continuously calculated with 
each new breath.
In previous studies the capnodynamic method with inspiratory holds provided CO mon-
itoring, however with unacceptable accuracy and precision during lung injury and elevated 
positive end-expiratory pressure (PEEP).
In this thesis we evaluated the revised capnodynamic method with expiratory holds in four 
separate studies. In a large animal model (study I-III), COEPBF was compared to a gold stan-
dard flowmeter placed around the pulmonary trunk during different hemodynamic, ventila-
tory, respiratory and metabolic challenges. Finally, COEPBF was compared to transpulmonary 
thermodilution in patients undergoing high risk abdominal cancer surgery. 
The capnodynamic method showed overall acceptable agreement and good trending abil-
ities in a variety of conditions familiar to a perioperative team. The agreement was tempo-
rarily disrupted after ischemia-reperfusion, however reestablished within five minutes. The 
accuracy was marginally affected during lung injury, both at high shunt fractions and after 
recruitment manoeuvre with PEEP adjustment. However, both precision and trending ability 
were maintained. In high risk patients, COEPBF showed good accuracy, acceptable precision 
and good trending ability in various conditions. The performance was especially robust after 
individualized lung recruitment and PEEP adjustment.
COEPBF may provide continuous CO monitoring with short response time, good trending 
abilities and acceptable agreement to guide hemodynamic treatment during surgery.
Keywords: cardiac output; carbon dioxide; capnography; hemodynamics; thermodilution; ani-
mal model; mechanical ventilation, reperfusion; lung injury; respiratory failure; surgery
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List of abbreviations
4Q Four Quadrant
ASA American Society of Anesthesiology
BL Baseline
CaCO2 Content of Carbon dioxide in arterial 
blood
CcCO2 Content of Carbon dioxide in pulmonary 
end-capillary blood 
CvCO2 Content of Carbon dioxide in mixed 
venous blood
CE Coefficient of Error
CaO2 Content of Oxygen in arterial blood
CcO2 Content of Oxygen pulmonary end-
capillary blood 
CO Cardiac Output
CO2 Carbon dioxide
COEPBF Effective pulmonary blood flow as assessed 
by the capnodynamic method with 
expiratory holds
COEPBFinsp Effective pulmonary blood flow as assessed 
by the capnodynamic method with 
inspiratory holds
COPAC Cardiac Output as assessed by the 
pulmonary artery catheter
COTPT Cardiac Output as assessed by the 
Transpulmonary Thermodilution method 
(in animal studies)
COTPTD Cardiac Output as assessed by the 
Transpulmonary Thermodilution method 
(in human studies)
COTS Cardiac Output as assessed by the 
ultrasonic flow probe
CV Coefficient of Variation
Δtn Duration of each breathing cycle
ELV Effective Lung Volume
EELV End-Expiratory Lung Volume
EPBF Effective Pulmonary Blood Flow
FACO2 Alveolar fraction of Carbon dioxide
FiO2 Fraction of inspired oxygen
Fr French (as a measurement of catheter size)
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GDT Goal-Directed hemodynamic Therapy
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n Current breath (in the capnodynamic 
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n-1 Previous breath (in the capnodynamic 
equation)
O2 Oxygen
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PAC Pulmonary Artery Catheter
Pb Barometric pressure
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PEEP Positive End Expiratory Pressure
P/F ratio Partial pressure of oxygen in arterial blood 
divided by inspired fraction of oxygen
PaO2 Partial pressure of arterial oxygen
PaCO2 Partial pressure of Carbon dioxide in 
arterial blood
PACO2 Partial pressure of Alveolar carbon dioxide
PeCO2 Partial pressure of Carbon dioxide in 
mixed expired air
PETCO2 Partial pressure of end-tidal Carbon 
dioxide
PP Polar Plot
RM Recruitment Manoeuvre
RQ Respiratory Quotient
RR Respiratory Rate
SCO2 Solubility coefficient for Carbon dioxide in 
blood
SD Standard Deviation
Sec Seconds
SV Stroke Volume
SVR Systemic Vascular Resistance
VCO2 Volume of carbon dioxide eliminated from 
the lungs
VTCO2n Volume of Carbon dioxide exhaled by the 
nth tidal volume
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Introduction
Since ether was first introduced in Boston 1846, anaesthesia providers have endeavored to 
keep patients safe during surgery. Swiping someone into his dreams carries great responsi-
bilities as vital functions are left in the hands of the caring team. Meticulous delivery of all 
essential ingredients, keeping the perfect physiological balance resides deep in the profession 
and can make all the difference for the patient. In high risk surgery, where rapid changes in 
vital functions are common, this quest can be arduous.  With technological advancements 
during the last two centuries; the sphygmomanometer measuring blood pressure, the elec-
trocardiograph showing the mystical electronic waves of the heart, the blood gas analysis, the 
pulse oximeter and the evolution of mechanical ventilation from the iron lung in the polio 
epidemic to the modern ventilator, has moved our boundaries and improved care. However, 
an important physiological parameter like the cardiac output, representing the volume of 
blood pumped by the heart each minute, is still difficult to measure reliably, especially during 
surgery where situations rapidly change. For the last few decades, a plethora of new technol-
ogy has emerged to provide useful information to the caring team, however, lapsing in critical 
situations. 
A new capnodynamic method, integrated in a modern ventilator, utilizes carbon dioxide 
in exhaled air to continuously estimate the cardiac output. Based on old physiological prin-
ciples, this method brings the heart closer to the lungs and could provide monitoring when 
needed the most. In this thesis we have vigorously tested the capnodynamic method to define 
its limits and reliability in various situations and ultimately its performance during high risk 
surgery. 
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Background
Goal-directed hemodynamic therapy (GDT) has been proposed to counteract the surgical 
stress response and oxygen demand by improving organ perfusion and oxygen delivery to 
the cells [1-4]. Cardiac output (CO) represents the flow to the body organs and is considered 
ideal to guide GDT [5,6]. Patients with reduced capacity to compensate for the increased 
oxygen demand in the perioperative period are more likely to acquire complications or even 
die within 30 days after surgery [7,8]. In fact, out of total 300 million surgical procedures 
performed each year, 10% are considered high risk accounting for the large majority of deaths 
and complications [9,10]. Even after moderate risk surgery, complications are relatively com-
mon [11,12] and may cause increased length of hospital stay, higher costs and importantly, 
decreased life expectancy per se [11,13]. 
A common pathway to postoperative complications is either hypoperfusion or edema, both 
affecting oxygen delivery to the cells [7,14]. The ultimate goal is therefore to accomplish a 
perfect physiological homeostasis for the individual patient with regards to both flow and 
pressure in a timely fashion to avoid organ dysfunction, complications and death. 
Numerous meta-analyses have proposed beneficial effect of GDT on perioperative compli-
cations and mortality, especially in high risk surgery [3,8,15,16]. However, recent evidence 
has questioned its benefit [17-20]. The benefit or lack thereof seems to depend on many 
factors; the patient population and type of surgery [8,21,22], the hemodynamic goals [23], 
composition of interventions (fluids/vasopressors/inotropy) [24], timing of implementation 
[3,25] and the monitoring methods used [23,26]. 
Professors Michael R Pinsky and Didier Payen wrote [27]: “No monitoring device, no mat-
ter how accurate or complete, would be expected to improve patient outcome, unless coupled 
to a treatment that itself improves outcome”. True as it can be, one might however turn the 
argument around and state: without hemodynamic monitoring, there is no GDT. If we are to 
react to and treat all the rapid physiological changes commonly encountered in the operation 
 theatre we are nevertheless dependent on continuous monitoring and preferably of both pres-
sure and flow. In this thesis we focus on CO, which is ideally used to guide flow in constantly 
changing hemodynamic situations, where heart rate and blood pressure sometimes fail to give 
reliable information on patient´s hemodynamic status [28]. The ideal CO monitor should 
be safe for the patient, easy to use and operator independent, produce continuous accurate 
and reproducible measurements with short response time and provide reliable trending when 
changes in CO emerge. 
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Cardiac output measurement
Historic review – the Fick method
In 1870 the German physiologist Dr. Adolf Fick (see figure 
1) presented his famous equation to calculate CO, originally 
derived from the oxygen consumption and the difference in 
arteriovenous content of oxygen between the right and left 
ventricle of the heart [29]. 
At the time, calculation of oxygen content in blood was 
impossible and expired air had to be equilibrated with alve-
olar gas to determine the content in mixed venous blood. In 
addition, the oxygen consumption could only be analyzed 
indirectly [30]. Provided with data from the laboratory in 
Ludwig and the assumption that humans and dogs have the 
same difference in arterio-venous content, Fick calculated 
the CO to be 5.4 L/min [31]. The equation describes a mass 
balance and can be used with other tracers or gases. Carbon 
dioxide (CO2) was early identified as an alternative to oxy-
gen, as it can be found in large stores in the body and both 
elimination and mixed venous/arterial CO2 tension (PvCO2 
and PaCO2) are more stable and easier to measure [32]. 
Gréhant and Quinquaud were the first to measure the pul-
monary perfusion in dogs using elimination of CO2 from the 
lungs in 1886 [31]. The first “non-invasive” measurements of 
CO in man, were made by Löwy and v. Schrötter in 1905, 
where they obtained oxygen gas samples through a catheter 
placed in a closed section of the lung (see figure 2) [31]. The 
Fick method did not become clinically available until right 
heart catheterization was introduced by Forssman in 1929. 
Cournand and Richards were the first to directly measure CO directly in humans. All three 
received the Nobel Prize in 1956 [33]. The direct Fick method was used clinically until the 
Figure 1. Adolf Fick, physiologist 
1829 -1901. Reprinted with permission from 
Springer Science+Business media, Inc. Science 
and technology in medicine by Andras Gedeon 
© 2006 
Equation 1. The Fick equation presented in 1870.
Figure 2. One of the first non-inva-
sive measurments of CO by Löwy 
and von Schrötter. Venous blood 
gas samples (O2 in this case) were 
obtained through a catheter placed 
in a closed off section of the lung 
[31]. Reprinted by permission from Spring-
er Science+Business media, Inc. Science and 
technology in medicine by Andras Gedeon © 
2006
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balloon flotation pulmonary artery catheter (PAC) was presented by Swan and Ganz in the 
1970´s [34] and thermodilution became the clinical reference method to calculate CO [35].
Thermodilution methods
Soon after its arrival, the PAC was used for hemodynamic monitoring during surgery and 
intensive care. The PAC calculates CO via trans-cardiac thermodilution  (triplicate cold saline 
boluses or thermofilament) and measures pressure (right atrial pressure, pulmonary artery 
pressure, pulmonary artery occlusion pressure) in the right sided circulation and enables gas 
sampling of mixed venous blood [36]. However, its use has greatly diminished in recent years 
as catheterization through the right heart is cumbersome, risks serious complications and 
the interpretation of the values provided is user dependent [36,37]. Besides complex cardiac 
surgery it is mainly used in patients in the intensive care unit (ICU) with right sided heart 
failure [38]. 
Transpulmonary thermodilution (TPTD) provides accurate measurement of CO, equiv-
alent to the PAC [39]. TPTD utilizes three cold boluses of fluid injected in a central vein 
catheter (CVC) and sensed by a thermistor tipped arterial catheter creating a thermodilution 
curve allowing calculation of CO by the Stewart Hamilton equation. The arterial catheter is 
most commonly inserted in the femoral artery but the PiCCO system offers catheters also for 
the axillary and brachial artery [40]. 
Both the PAC and TPTD are considered invasive methods that requires special skills 
and equipment. Both techniques are considered time consuming and are rarely used in the 
non-cardiac perioperative settings [41,42]. 
Minimally and non-invasive methods
In recent years, many minimally and non-invasive CO monitors have emerged with different 
qualities and limitations [43]. These new monitors are commonly compared to the thermo-
dilution methods to estimate their accuracy, precision and trending ability. However, they all 
have technology-specific and device-specific problems when used in routine clinical practice 
(see table 1 for overview) [44-47].
In summary 
The thermodilution methods are too invasive and complex for routine use in non-cardiac 
surgery. Validation studies have found the new minimally- and non-invasive monitoring 
methods, each with its own advantages and limitations, to be less reliable than thermodilution 
based methods. This pertains especially to rapid changes in vascular volume and resistance 
which is a common feature during major surgery [45,48-51]. This underlines the need for a 
feasible minimally- or non-invasive CO monitor which is both fast, safe and reliable during 
hemodynamic changes providing continuous, accurate monitoring of trends during surgery 
in a safe manner [23,52].
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Carbon dioxide and cardiac output monitoring
A journey from the mitochondria to the lungs and back
Carbon dioxide is the end-product of energy metabolism; continuously produced in large 
amounts (200 ml/minute) in the mitochondria as the final catabolite of aerobic oxidative 
phosphorylation and in small amounts in conjunction with anaerobic glycolysis. Via concen-
tration gradients, CO2 diffuses through the cytoplasm and extracellular fluid into the nearest 
venous capillaries, promoting the release of oxygen from hemoglobin (Bohr effect). Carbon 
dioxide is transported via the bloodstream mainly as bicarbonate (80-90%) or bound to pro-
teins (5-15%) including hemoglobin, as well as dissolved in plasma (5-10%). Via the right 
heart, blood full of CO2 is pumped into the lungs (i.e., pulmonary blood flow) which approxi-
mates the total cardiac output. When it reaches the pulmonary capillary network, it is released 
again as CO2, with the help of hemoglobin-bound carbonic anhydrase catalyst and the Hal-
dane effect when hemoglobin binds to oxygen again. CO2 then diffuses from the perfused 
alveoli, into the alveolar gas and lastly eliminated by alveolar ventilation to the atmosphere.
A note on pulmonary physiology
The pulmonary circulation is a low-pressure circuit accommodating to approximately the 
same flow as the systemic circulation, both during exercise and rest. The volume of blood in 
the pulmonary circuit at any given time in a normal adult is about 0.5-1.0 L and is mainly 
affected by body posture. The pulmonary blood flow is determined by the driving pressure, 
the difference between the mean intravascular pulmonary artery pressure (mPAP) and the 
pressure in the left atrium. Unlike the systemic circulation, arteries, capillaries and veins con-
tribute equally to resistance and can adapt to large changes in flow by either passive dilatation 
and/or recruitment of more capillaries, producing only small changes in pulmonary artery 
pressure. 
PVR as the product of the driving pressure divided by the pulmonary blood flow can be 
affected in many ways; ∆lung volumes (↑ at both extremely high and low volumes); ∆ alve-
olar pressure (↑ at high pressure compressing the capillaries); ∆ autonomic system (small 
effect in human); hypoxia (↑ due to reflex contraction of smooth muscle cells, diverting blood 
flow to the more oxygenated areas); and drugs (mainly ↓ to counteract pulmonary arterial 
hypertension).
In healthy lungs the ventilation (V) and perfusion (Q) through the capillary network are 
closely matched and often presented in terms of a ratio (V/Q). Both V and Q are preferen-
tially distributed to the dependent and central regions of the lungs, mainly because of gravity 
and branching of the bronchial- and vascular tree. Theoretically if V and Q were uniformly 
distributed the ratio for each alveolus would be 0.8. Pulmonary disease commonly causes 
mismatch in the V/Q ratio and sometimes mechanical ventilation is used to try to restore 
the balance. Regions with perfusion but no ventilation have a V/Q ratio approaching zero 
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and regions where there is ventilation but no perfusion the ratio approaches infinity. Severely 
injured, mechanically ventilated lungs can have ratios from zero to infinity.
Shunt
The degree of admixture of venous blood with end-capillary blood is commonly divided into 
anatomical and physiological shunt. In a healthy normal person, there is always some anatom-
ical admixture of blood mainly via the bronchial- and Thebaesian veins and physiologically 
from regions of the lung with a V/Q ratio >0 and <1. Pathological states such as atelectasis, 
bronchial obstruction and congenital heart disease, with flow from right to left, will increase 
the shunt. Shunt is calculated as a fraction, however precise volume or anatomical pathway 
cannot be defined. When calculated during FiO2 1.0, the physiological component from dif-
ferent V/Q regions is minimized and only anatomical and pathological shunt estimated. For 
more details, please read the method section.
Dead space
The portion of the tidal volume that is not involved in the gas exchange is called dead space 
and as with the shunt, it is divided into anatomical (VDaw) and alveolar components (VDalv). 
Together they comprise what´s called physiological dead space (VDphys), commonly calcu-
lated with either Bohr or Enghoff formula. Enghoff dead space (PaCO2-PeCO2/PaCO2) is mea-
sured with volumetric capnography (mixed expired partial pressure of CO2 – PeCO2) and 
arterial blood gas sample and represents the global V/Q mismatch (units A-C in figure 3) as 
it includes venous admixture from low to zero V/Q areas. Bohr dead space (PACO2-PeCO2/
PACO2) can be measured continuously, breath by breath with volumetric capnography and 
represents V/Q areas >1 to infinity (see figure 3). 
Figure 3. A simplified model of the lungs (left) showing A) shunt (V/Q = low to zero), B) an ideal unit, C) dead space 
and volumetric capnography (right) which describes the transport of CO2 by convection (VDaw) and diffusion within 
alveoli (VTalv). The area under the curve (greyblue) is VCO2 for each breath and PACO2, PETCO2 and PeCO2 are the 
mean alveolar, end-tidal and mixed expired partial pressures of CO2. Kindly provided by Fernando Suarez Sipmann.
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Differential Fick principle 
In 1980, Gedeon et al described a new approach to circumvent invasive measurements of 
mixed venous CO2 content (CvCO2) and called it the differential Fick’s method [55]. The new 
method was dependent on a change in the alveolar CO2 concentration; large enough to be 
measured accurately with capnography and small enough to keep CvCO2 stable (see equation 
3).
The essential change in alveolar CO2 can be accomplished by three means; (1) changes in 
the alveolar ventilation as originally described by Gedeon and applied by both the capnody-
namic method, described in this thesis and the Capnotracking method (see below) [55], (2) 
changes in dead space by adding a rebreathing circuit as originally described by Capek et al 
[56] and used in the NICO system with different software versions (see below) [32,57] or (3) 
adding CO2 to the inspiratory gas by different means [58]. 
Non-invasive calculations of EPBF, as described above, can be derived from the Fick method 
in the following way. Rewriting equation 1 with CO2 instead of O2 and where VCO2 represents 
the elimination of CO2 from the lungs, and CvCO2 and CcCO2 the content of CO2 in mixed 
venous and pulmonary capillary blood, respectively (see figure 4 for visual explanation);
Equation. 2. The equation for effective pulmonary blood flow, based on the Fick principle. For simplicity we use 
EPBF when referring to the non-shunted CO. In Gedeon studies (and others) this entity has had different names.
By altering the CO2 elimination between two time points (A and B) at steady state we can 
write;
Equation 3. Two differential equations combined at two time points, A and B.
If we assume CvCO2 to be unchanged between the two time points A and B it can be shortened 
out and the EPBF can be expressed as;
Equation 4. EPBF as a product of the change in CO2 elimination (VCO2) 
divided by the change in content of CO2 in pulmonary capillary blood.
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CcCO2 can be estimated non-invasively by measurement of alveolar or end-tidal CO2 partial 
pressure (PACO2 or PETCO2) combined with the solubility coefficient of CO2 in blood (SCO2). 
The SCO2 is affected by the hemoglobin level and the oxygen saturation per se [56]. The final 
equation to describe the pulmonary flow using changes in alveolar partial pressure during 
steady state is therefore;
Equation 5. EPBF as a product of the change in CO2 elimination from the lungs divided by the change in 
alveolar (or end-tidal) partial pressure of CO2 and the solubility coefficient for CO2 in blood.
To accomplish the required changes in PACO2 promptly, without affecting CvCO2 returning to 
the lungs (recirculation), mechanical ventilation is preferred. 
Gedeon’s original studies
In Gedeon´s original study from 1980 in anesthetized dogs, the alteration in PACO2 was 
achieved by changes in the I:E ratio to have the least effect on the lung mechanics and dead 
space [55]. The results showed good agreement with thermodilution, however, the method 
required 15 minutes to achieve a new steady state for an additional measurement.
In 1985, Gedeon and colleagues applied calculations of EPBF in eight “seriously ill” patients 
with data from Wolff et al (1982) and 23 patients in “acute pulmonary failure” from Klose and 
Oswald (1981) to compare with oxygen delivery, static compliance and PaO2 at different PEEP 
levels. They observed that oxygen delivery was coincided with EPBF rather than the highest 
compliance or PaO2 and speculated that EPBF could be used to individually select the best 
PEEP for oxygen delivery.
With further refinement, Gedeon and his co-workers introduced two new features in 2002; 
a single breath hold (3 sec) for less interference in alveolar ventilation and effective lung vol-
ume (ELV) to account for the total amount of CO2 stored in the lungs at time of change in 
PACO2. After testing different equations they applied the most promising one to 18 patients 
following CABG operation and compared EPBF with thermodilution (Bias -0.18 L/min and 
standard deviation (SD) 0.62 L/min). 
Capnotracking 
In 2006, Peyton et al described the first breath-to-breath “capnodynamic” approach to cal-
culate CO. Based on Gedeon’s previous work, the tidal volumes where changed (±200ml) 
for every six breaths. The method was compared to an ultrasonic flow probe placed around 
the pulmonary trunk in sheep and showed relatively good agreement. However, there were 
difficulties achieving stable measurements. In 2012, Peyton et al presented a modified method 
he called “Capnotracking” which involves an automatic calibration manoeuvre where alveo-
lar ventilation is changed by altering the respiratory rate and the I:E ratio to obtain a base-
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line measurement of EPBF. Changes in EPBF are then “tracked” via measured elimination of 
VCO2 and PETCO2. The system includes a shunt correction obtained non-invasively and was 
recently upgraded with additional calibrations to increase precision [59,60]. Impressively, in 
patients undergoing cardiac surgery and liver transplantation with a wide range of CO and 
receiving vasopressor treatment, Capnotracking attained low bias (-0.3 L/min) and a preci-
sion of 38.3% when compared to thermodilution (PAC). Concordance rate when 15% change 
in CO was achieved was 81.4%. Interestingly, there was no correlation between lung function 
measured pre-operatively and the PE. 
Partial carbon dioxide rebreathing
In 1988, Capek et al described another approach to estimate CO[56]. Based on Gedeon’s 
studies, a rebreathing loop with automated opening valve near the Y-piece was added to the 
patient’s breathing system to increase dead space and achieve the desired changes in VCO2/
CaCO2. The procedure included a 30 sec rebreathing time which kept CvCO2 stable during 
the 3.5 minutes each measurement lasted. Intuitively, hemoglobin was added to the equation 
as large changes could cause errors in the obtained value. Since then a few semi-continu-
ous partial rebreathing instrument have been introduced commercially; NICO (Respironics, 
Murrysville, PA, USA) and the upgraded NM3 (Philips Respironics, Wallingford, CT, USA). 
Correction for shunt fraction is added non-invasively via pulse oximetry, FiO2 inserted into 
Nunn´s iso-shunt fraction plots. In a recent meta-analysis the partial rebreathing CO2 meth-
ods had the best agreement to a thermodilution method compared to the other non-invasive 
methods (bias -0.2 L/min, LoA -2.4 to 2.0 L/min and PE 40%). However, the partial CO2 
rebreathing methods are not suitable for use in the operation theatre, because of discontinuity 
and each measurement requires a steady state. 
The capnodynamic equation
In 2013, Albu et al presented a new developed capnodynamic equation, allowing continuous 
measurements of EPBF, ELV and CvCO2. The capnodynamic equation can be explained in the 
following way.
Figure 4. The flow of CO2 through the lung. Mixed 
venous blood with certain partial pressure (PvCO2) 
and content (CvCO2) of CO2 flows into the lung 
where part of the blood flow is shunted past the 
alveoli and admixtures arterial blood. Within the 
alveolar capillary unit (dotted lines) CO2 diffuses 
into the alveoli (Haldane effect) and oxygen dif-
fuses from the alveoli into the blood and binds 
hemoglobin. As CO2 diffuses easily over the alve-
olar membrane, equilibrium with PACO2 is quickly 
established, which then can act as a surrogate for 
the pulmonary capillary content of CO2 (CcCO2). 
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The Fick principle, rewritten from equation 1 with CO2, describes the blood flow outside of 
the whole line in figure 4 and can be rewritten as:
Equation 6. VCO2 is the elimination of CO2 from the lungs, PBF is the total pulmonary blood flow 
and CvCO2 and CaCO2 represents the mixed venous and arterial content of CO2 respectively.
In a steady state, where the amount of CO2 in the lungs is constant the inflow of CO2 is equal 
to the outflow and equation 6 can be expressed:
Equation 7.
With the same argument, the balance within the dotted lines in figure 4 can be written as
Equation 8. EPBF is the non-shunted pulmonary blood flow and CcCO2 is the capillary content of CO2.
By changing the alveolar PACO2 between two different time points equation 8 can be further 
developed into:
Equation 9. The capnodynamic equation. See explanation below.
ELV, effective lung volume (L) containing CO2 at the end of expiration. 
EPBF, effective pulmonary blood flow (L/min). 
n, current breath.
n-1, previous breath. 
FACO2, alveolar CO2 fraction (of the total gas volume) estimated from the midpoint value 
(phase III) of the volumetric capnogram. 
CVCO2 mixed venous CO2 content (Lgas/Lblood). 
CcCO2n, lung capillary CO2 content (calculated from FACO2, the solubility of carbon dioxide in 
blood and hemoglobin concentration). 
VTCO2n, volume (L) of CO2 eliminated by the current, nth, breath. 
Δtn, current breath cycle time (min).
The capnodynamic equation describes the mole balance between the flow of CO2 delivered to 
the parts of the lungs participating in the gas exchange (EPBF), the volume taking part in the 
gas exchange (ELV) and the volume of CO2 excreted from the lungs (VTCO2). Normally there 
is no difference in CO2 between the actual and the preceding breath as approximately the 
same amount of CO2 is delivered to the lungs as is excreted. However, when short inspiratory 
or expiratory pauses are repeatedly introduced, small changes in FACO2 concentration are 
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created between each breath (0.5 -1.0 kPa). In a loop of 9 to 10 breaths, equally many equa-
tions are formed and then stacked together. By optimizing the fit between a one compartment 
lung model and the measured data, the three unknown variables (ELV, EPBF and CvCO2) 
can be solved with a least square error optimization. The breathing pattern is automatically 
controlled by the ventilator which provides continuous calculations of EPBF where each value 
represents the average of the preceding 9 or 10 breaths. Each new breath creates a new equa-
tion which replaces the oldest in the equation system.
In the Albu et al study from 2013, the capnodynamic equation was used to calculate ELV 
and compare to end-expiratory lung volume (EELV) in anesthetized rabbits [61]. The essen-
tial changes in CO2 were attained by automatic alterations in the I:E ratio in a predetermined 
breathing pattern including five consecutive normal breaths (I:E 1:2) with five breaths with 
inspiratory holds (I:E 1.5:1). EPBF was not reported in this study. For further information on 
ELV as an estimation of lung volumes, please read [62] and a recently published thesis [63].
The capnodynamic method with inspiratory holds
In 2014, Hällsjö Sander et al further evaluated the capnodynamic method with inspiratory 
holds to estimate CO (COEPBFinsp) in a large animal model in a series of induced hemodynamic 
changes [64]. When compared to an ultrasonic flow probe placed around the pulmonary 
trunk, accuracy, precision and trending were equivalent to the COPAC (PE 47 vs 49% and 4Q 
plot 97 vs 95-100%) [64]. In a following study [65], COEPBFinsp was evaluated with the same 
reference method during changes in PEEP, both before and after lung injury (lung lavage sur-
factant depletion). As expected, lung injury created a large shunt fraction (up to 36%) affect-
ing both accuracy and precision. As expected, with no shunt correction incorporated into 
the method, COEPBFinsp underestimated CO after lavage. However, trending ability was largely 
unaffected. Unexpectedly, COEPBFinsp overestimated CO at higher PEEP levels both before and 
after lung injury. There was no correlation between bias and dead space (Vd/Vt) calculated 
with the Bohr equation. The authors concluded that the phasic elevated airway pressure par-
allel to the inspiratory pause per se, may have disturbed the carbon dioxide signal, causing 
errors in the obtained COEPBFinsp value [65]. 
The current revised capnodynamic method
After the studies conducted by Albu et al and Hällsjö Sander et al, the capnodynamic method 
was revised and modified. The difference in PACO2, essential for the capnodynamic calcu-
lations, were now attained via extension of the expiratory part with six normal breaths in 
between, in total 9 breaths creating 9 equations as described before. 
The revised capnodynamic method has recently been compared to a suprasternal Dop-
pler in small children (6-23 months, 7.8-10.5 kg) during cleft lip surgery. COEPBF changed 
as expected to both increased PEEP (9 cmH2O) and atropine, however, the agreement with 
the suprasternal Doppler was poor, which the authors prescribed to limitations of the ref-
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erence method. An identical study protocol was repeated in piglets with an ultrasonic flow 
probe on the pulmonary trunk as reference. The agreement and trending ability reported was 
good [66]. The same small animals were (in another study protocol) subjected to hypoxia and 
inhaled nitric oxide (iNO), without affecting the performance of the method [67]. 
In summary, the current capnodynamic method has been in development for almost 35 
years and is based on well-known physiological and mathematical principles. It provides 
non-invasive calculations of EPBF (CO minus shunt) and the ELV (proposedly the volume in 
the lungs that participates in the gas exchange).
How to validate a new cardiac output monitor?
As elegantly described by Saugel et al [68]: “CO is a hemodynamic variable that changes over 
time and is modified by a variety of factors closely related to oxygen supply and consumption, 
such as cardiac preload, cardiac afterload, and cardiac contractility. When performing valida-
tion studies for CO-monitoring technologies, it has therefore to be kept in mind that both the 
studied technology and the reference technology are aiming to hit a moving target”.
Inherent precision 
Describes the precision of the method during repeated measurments at steady state and is 
defined as two times the coefficient of variation (CV) where CV= SD/mean. Inherent preci-
sion is sometimes used to calculate the least significant change (LSC) which is the minimum 
change that can be detected as a “real” change by the method [69]. LSC is calculated as inher-
ent precision × √2 and can be used to define exclusion zones (see trending ability below). 
Accuracy and precision
The accuracy describes how close to the actual or real value the measurement is, whereas the 
precision describes how close together the measurements are [69]. A method consistently 
measuring CO 3 L/min when the “real” value is 5 L/min would be considered inaccurate but 
precise.
The Bland-Altman plot, introduced in the 1980s, provides visual assessment of the agree-
ment between two methods by plotting the difference between the paired measurements 
against the average of the measurements [70]. The bias gives us estimation of accuracy (corre-
sponding to the systematic error between both methods) and should preferably be as close to 
the X-axis as possible. The standard deviation of the bias (SDbias) gives us the precision (cor-
responding to random error between the methods agreement) [69]. The level of agreement 
(LoA) is calculated as bias ± 1.96xSDBias and spans an interval that covers (with 95% certainty) 
the average differences between the two methods (see fig 5) [71]. 
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Percentage error
Level of agreement (LoA) is independent of the magnitude of the mean CO; for example, a 
LoA of 1 L/min would be considered excellent in a population with a high mean CO (hyper-
dynamic circulation) but not in a pediatric population where the mean CO is low. Critchley 
and Critchley proposed that percentage error (PE – sometimes referred to as mean error) 
should be used for more righteous comparison of the population studied and is calculated 
as [72]. The Critchley brothers established a cut-off point for interchangeability 
between the compared methods at 28.3% (rounded up to 30%) which was entirely based on 
the inherent precision of the PAC itself* [72]. However, it should be noted that the calcula-
tions were mainly based on data from two studies measuring COPAC during stable hemody-
namic situations and a simulation model [35,73]. Nevertheless, the Critchleys criteria for PE 
is commonly used as a priori in CO method comparison. To avoid erroneous conclusions, it 
is important that the inherent precision of the reference method itself is low (<20%), as the 
Bland-Altman analyses cannot take standpoint of which is better than the other. 
*The calculated inherent precision of the PAC was around 20% in these studies. If the new method was 
to attain equal or better precision than the PAC, the desired precision of the new method would have to be 
20% or lower. The cut-of was calculated as √(202+202 ) =28,3 ≈30%.  
Percentage error in a clinical perspective
In their meta-analysis from 2010, Peyton and Wong challenged the Critchley and Critchley 
criteria stating that none of the non-invasive methods in the analysis achieved the 30% cut-off 
and suggested a PE 45% could be used when two methods are compared in clinical situations. 
The authors argued that even the PAC itself did not live up to the 30% criteria in clinical situ-
Figure 5. An example of Bland Altman plot. The whole pink line represents the mean bias and represents the 
accuracy. The precision is calculated from the mean bias and the standard deviation of the bias times 1.96 (or a 
factor adapted from a t-table, as in study II and III). The percentage error (PE) takes the mean cardiac output (CO) 
into account.
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ations, i.e. during cardiac surgery when compared to ultrasonic flow probe around the aorta, 
as well as during hemodynamic changes in a porcine model [74,75]. In a recent follow up 
meta-analysis by Joosten et al, none of the new non-invasive methods came close to the 30% 
cut off when compared to thermodilution methods (see table 1). A major limitation of these 
studies is the clinical heterogeneity and selection bias, as the large majority is conducted in 
the cardio-thoracic suites or ICU, not reflecting the group of patients intended for their use. 
Recently, Pinsky and his group, somewhat provocatively stated there is no meaning in com-
paring new CO methods to the PAC, both due to safety reasons and the high “intrinsic error”. 
Based on the observation/results that most of these methods show good accuracy (low bias), 
we should shift our focus to the ability of these methods to trend dynamic changes in CO [76]. 
Trending during changes in cardiac output
The trending ability of new methods is commonly assessed by calculating the concordance of 
the change, in both direction and magnitude, using either the four-quadrant (4Q) plot and/
or polar plot [68,77]. The 4Q plot calculates the concordance rate (%) by dividing the number 
of data points that change in the same direction (that are within the two quadrants of agree-
ment) with the total number of data points. When one device detects a larger change than the 
other, the paired value lies closer to the horizontal or vertical axis. If the detected change is the 
same in both devices, the paired value falls on a line at 45° [68]. 
The polar plot methodology, derived from the 4Q plot, is based on non-linear transforma-
tion to polar coordinates, where each paired value receives an angle and a radius. The angular 
bias is the mean of all polar angles and the radial limits of agreement is the sector that includes 
95% of the data points [78]. An angular bias of ±5° and radial limits of ±30° indicates good 
trending ability. An exclusion zone of 10% is commonly applied to eliminate values with only 
small change (background noise), however in the polar plot, highly disconcordant values are 
also excluded, which is a limitation to the method. The concordance rate is calculated from 
number of points within the radial limits (±30°) divided all data points outside of the exclu-
sion zone.
There is no clear consensus on which concordance rate is clinically acceptable, although 
equal or more than 90-92% are commonly used for both methodologies [68,77]. 
As with accuracy and precision, the performance of the minimally and non-invasive meth-
ods rarely reaches the desired concordance. However the development over the years has 
been positive, resulting in better agreement and trending ability [51]. 
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Aims
The overall objective of this thesis was to evaluate the revised capnodynamic method ( COEPBF), 
for estimation of CO and ability to track changes in a large animal model and in patients 
undergoing high risk abdominal surgery.
Specific aims:
In a large animal model compared to an experimental gold standard refer-
ence method:
1. To evaluate COEPBF at different CO, tidal volumes and PEEP for agreement and trending 
ability.
2. To evaluate COEPBF for agreement during transient and sustained changes in mixed venous 
CO2 content after reperfusion and hypercapnia and trending ability during sustained high 
mixed venous content of CO2.
3. To evaluate COEPBF during severe lung injury, both at high shunt fractions and after lung 
recruitment and the trending ability during both these conditions.
In high risk abdominal surgery:
4. To evaluate COEPBF for agreement and trending ability compared to a transpulmonary 
thermodilution during a variety of clinically relevant hemodynamic changes. 
28
Thorir Sigmundsson
Material and methods
Detailed descriptions of the experimental methods can be found in the method section in 
respective paper.
Ethical consideration
Studies I-III were approved by Uppsala animal research ethical committee (nr. C 47/15) and 
performed at the Hedenstierna laboratory in Uppsala University, Sweden. Result are reported 
according to the ARRIVE guidelines [79].
In total 26 pigs of both sexes with a mean weight 35 kg (range 32 – 44 kg) were collected 
from the same breeding colony (Mångsbo Farm, Uppsala, Sweden). At the farm they had 
unlimited access to tap water and food on a standardized schedule and kept in a light and 
temperature controlled environment.
Study IV was approved by Stockholm regional ethics committee (Dnr. 2010/1296-31, 
2012/1477-32, 2015/170-32, 2017/1096-32, 2017/2327-32) and registered at US National 
Institutes of Health via clinicaltrials.gov (Identifier: NCT03444545) and conducted in accor-
dance with good clinical practice and the Helsinki declaration [80]. Results are reported 
according to the GRRAS guidelines [81].
Studies I-III
Anesthesia and preparation
After weighing, the animals were sedated with an intramuscular injection of 0.04 mg/kg atro-
pine, 6 mg/kg tiletamine-zolazepam and 2.2 mg/kg xylazine chloride followed by insertion of 
an intravenous line in a peripheral vein in the ear. After a bolus dose of 5μg/kg fentanyl, an 
intravenous infusion of ketamine 30 mg/kg/h, midazolam 0.1mg/kg/h and fentanyl 4 μg/kg/h 
was administered for maintenance of anesthesia and rocuronium 2mg/kg/h for muscle relax-
ation. Anaesthetic level was evaluated prior to administration of muscle relaxant by applying 
pain stimuli to the fore hoof with forceps. If necessary, additional injections of fentanyl or 
midazolam were given. The animals were intubated via open tracheostomy and ventilation 
was started in a volume-controlled mode (Servo-i; Maquet, Solna, Sweden) with a tidal vol-
ume of 8 mL/kg and FiO2 0.4 except in paper III were FiO2 1.0 was used during lung injury. 
Positive end-expiratory pressure (PEEP) was set to 5 cmH2O and the respiratory rate was 
adjusted to obtain a systemic arterial partial pressure of carbon dioxide (PaCO2) of approxi-
mately 40 mmHg during inherent precision and baseline measurement.
An intravenous infusion of Ringer’s lactate was infused at the rate of 10 mL/kg/h through-
out the experiment. 
If hypovolemia was suspected, i.e. significant tachycardia and/or hypotension, additional-
colloid solution was administered in boluses of 100-200 mL.
Pulmonary artery catheter (Edwards Lifesciences Corp., Irvine, CA, USA) was inserted in 
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the internal jugular vein for blood sampling, pressure and CO recordings. Via left sided thora-
cotomy, a flow probe was mounted on the pulmonary trunk (see figure 6). The chest was then 
closed and the animals repositioned in the supine position. 
Via ultrasound guidance, a 10 French (Fr), 80 cm thrombectomy catheter (Dispomedica 
GmbH, Hamburg, Germany) was inserted into the inferior cava vein for controlled preload 
reduction. 
A urinary catheter was placed via small surgical incision into the urinary bladder and the 
body temperature was maintained at 38-39°C with a warming mattress and blankets.
In study I, a 13.5 Fr arterial catheter was inserted in the femoral artery for controlled 
bleeding and an 8 cm, 4 Fr thermistor-tipped (Pulsiocath, Pulsion, Munich, Germany) in 
the contralateral femoral artery for pressure recordings and transpulmonary thermodilution. 
In study II and III the arterial catheter for pressure recordings was inserted in the carotid 
artery. In study II, a 12 Fr stent graft balloon catheter (Reliant®, Medtronic Inc. Minneapolis, 
MN, USA) was inserted into the femoral artery with ultrasound guidance and placed in the 
abdominal aorta just beneath the diaphragm, verified with fluoroscopy.
When the preparation was finished the animals were left to recover for 30 minutes before 
precision and baseline measurements were obtained. When all the study measurements were 
secured, the animals were euthanized in deep anesthesia by potassium chloride injection.
Study IV
Patients undergoing high risk abdominal surgery were scanned for eligibility from the sur-
gical planning program (Orbit 5) on dates when at least two members of the research team 
were available. At these dates, patients older than 18 years without any known chronic lung 
emphysema or symptomatic coronary artery disease with an indication for invasive hemody-
namic monitoring were offered to participate in the study. Patients received verbal and writ-
ten information at the preoperative clinic or via telephone and email, at least five days before 
planned surgery. All patients planning to participate in the study were visited at the surgical 
department at admission for quick review of the study details and to obtain written consent. 
Initially, 25 patients were planned to participate in the study. After the initial data analy-
sis, the protocol was changed, and recruitment manoeuvre (RM) and PEEP adjustment were 
included in additional 10 patients.
Anesthesia and preparation
At the morning of surgery, patients arrived in the operation theatre where a designated 
research team including an anesthesiologist and a nurse assisted from start in addition to the 
existing anesthesia team (attending anesthesiologist and anesthesia nurse). After safe sur-
gical checklist assessment, vital signs were measured and an epidural catheter inserted in 
a light sedation. Anesthesia was induced with a bolus of propofol, short acting opioid and 
neuromuscular blockade to facilitate intubation. Patients were mechanically ventilated in a 
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volume-controlled mode (Servo I, Maquet Critical Care AB, Solna, Sweden), with tidal vol-
umes (VT) 6-8 ml per predicted body weight (kg). A mainstream infrared sensor was used 
to measure concentration of expired CO2 essential for the capnodynamic calculations (see 
details below). 
A 7 Fr central vein catheter was inserted in the internal jugular vein and a 5 Fr therm-
istor tipped catheter (Pulsiocath, PV2015L20F or PV2014L08A; Pulsion Medical Systems 
SE, Feldkirchen, Germany) in either the femoral or axillary artery, determined by type of 
surgery and patient position. Both catheters were inserted with ultrasound guidance under 
strict sterile conditions. Maintenance of anesthesia was secured with propofol in a target-con-
trolled infusion (TCI) and complemented with remifentanil infusion if indicated. All patients 
received maintenance fluid, either buffered 2.5% Glucose solution or Ringer Acetate 1 ml/
kg/h. An esophageal Doppler probe (Cardio Q, EDM; Deltex Medical, Inc., Chichester, UK) 
was inserted as part of the standard method for fluid optimization during open abdominal 
surgery at Karolinska University Hospital and used by the anesthesia team to assess the need 
for any extra fluids during the operation. A final checklist was carried out before start of the 
research protocol. The epidural was activated as a separate step in the experimental protocol 
(see below) and infusion with ropivacaine 20-25 mg/h was continued until 30 minutes before 
end of surgery when the infusion was changed to a postoperative mixture of ropivacaine and 
sufentanil (2 mg/ml + 0.5 ug/ml), 6 to 8 ml/h. Core temperature was maintained at 36-37°C 
with a forced air warming system.
Cardiac output monitoring
Ultrasonic flow probe
The reference method for CO in study I-III was an ultrasonic flow probe with an Ultrafit liner, 
18-20mm (AU series Confidence Flowprobe®) connected to an accompanying monitor (T 
401; Transonic system Inc, Ithaca NY, USA) (COTS) [82]. Ultrasonic gel was applied between 
the vessel and the liner to secure best possible signal. The probe transmits ultrasound signals 
back and forth between two opposite transducers with an X-beam and custom made crys-
tals to eliminate positional sensitivity [83]. It measures the wave time intersecting the flow 
between the transducers and is not dependent on cross sectional area as the Doppler technol-
ogy. COTS and COEPBF were recorded simultaneously, where each reading was an average of 
approximately five to ten seconds.
The reported precision for the COTS is 6% and was 1% at baseline conditions in our preced-
ing animal studies [64,82].
Pulmonary artery catheter
A balloon-tipped 7.5 Fr pulmonary artery catheter (PAC) (Edwards Lifesciences, Irvine, CA, 
USA) was inserted via the right jugular vein and floated through the right atrium and right 
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Figure 6. A flow probe attached to an Ultrafit liner mount-
ed on the pulmonary trunc in one of the research animals. 
Used with permission (Caroline Hällsjö-Sander©). 
ventricle into the pulmonary artery. The PAC was used for sampling of mixed venous blood 
for gas analyses and calculation of hemodynamic parameters.
The PAC was mainly used for CO measurements (COPAC) in study I. In addition values for 
COPAC were shown in one figure in study II for comparison during reperfusion. Calculation 
of CO was performed with three 10 mL boluses of ice cold saline, performed after the COTS 
and COEPBF readings as the injections caused instability in the CO2 signal in the expired gas. 
Transpulmonary thermodilution 
Transpulmonary thermodilution (TPTD) was used as a reference for CO (COTPTD) and mea-
sures the change in temperature when cold saline traverses from a central vein catheter in the 
superior vena cava, through the right heart, pulmonary circulation, the left heart, aorta and 
finally acquired by a thermistor tipped centrally inserted arterial catheter (either the femoral 
or axillary artery). When three cold boluses are used, the method is considered accurate and 
precise when compared to the clinical gold standard (PAC) and highly reproducible in criti-
cally ill patients [84]. In this study we used the PiCCO2® monitor (Pulsion Medical Systems 
SE, Feldkirchen, Germany) where each COTPTD represents the average of triple thermodilu-
tions with 10-, 15- or 20-ml ice cold Ringer Acetate. Measurements were considered accurate 
based on visual assessment of the thermodilution curve and if the difference between the 
three measurements was less than 15%. If these requirements were not fulfilled, one or two 
additional thermodilutions were performed and the deviating values were removed from the 
average. One designated member of the research team was responsible for performing all the 
thermodilutions in each case. 
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Capnodynamic method
The capnodynamic method estimates CO based on effective pulmonary blood flow calculated 
by the capnodynamic equation. The equation describes the mole balance of CO2 transport in 
the lungs and the rate of change of the CO2 content in the lungs achieved by the superimposed 
breathing pattern (see background section).
In the revised method, short automatic expiratory pauses (1-2 seconds in the pigs and 4-5 
seconds in humans) are introduced in three out of every nine breaths resulting in small differ-
ences (0.5-1 kPa) in the alveolar concentration of CO2 between each breath (see fig 7). Using a 
least square-error optimization of the fit between the left and right side of the equation, ELV, 
EPBF and CvCO2 can be calculated from a set of 9 equations (breaths). Each breath creates a 
new equation and replaces the last equation, providing continuous calculations that represent 
the average of the preceding 9 breaths. 
A mainstream infrared sensor (Capnostat-3, Respironics Inc, Wallingford, CT, USA) was 
used for volumetric capnography. Gas flow was analyzed by the flow sensor incorporated in 
the ventilator (Servo I, Maquet Critical Care AB, Solna, Sweden) and transmitted to a con-
nected computer where all the mathematical analysis was carried out with a software written 
in Matlab™ (The Mathworks Inc, Natick, MA, USA).
In study I-III COEPBF and COTS readings were obtained simultaneously and were based on 
an average of approximately 5-10 s. Thermodilution measurements were performed subse-
quently to not disturb the other measurements due to potential cold-induced bradycardia. 
In study IV, COEPBF was photographed as the first thermodilution was initiated and again 
when value for the third thermodilution appeared on screen. The value for each measurement 
was therefore an average of three thermodilutions (COTPTD) and two COEPBF values. 
Lung injury
Lung injury was induced with a combination of lavage and ventilator induced lung injury 
(VILI). Isotonic saline (30 ml/kg) at 37°C was used to lavage the lungs and deplete them from 
surfactant. For additional injury, subsequent 30 – 60 min of injurious mechanical ventilation 
combining zero PEEP with high inspiratory pressure (30 – 35 cmH2O).
Calculation of shunt and dead space
Shunt fraction was calculated using Berggren’s formula ; where Qs/Qt = shunt 
fraction; CcO2 = pulmonary capillary content of oxygen; CaO2 = arterial content of oxygen 
and CvO2 = mixed venous content of oxygen [85]. 
Oxygen content (ml/dl) was calculated = ; where Hb = 
hemoglobin concentration (g/dl); 1.34 represents the amount of oxygen (ml) bound to hemo-
globin (g/dl); SxO2 = oxygen saturation in respective blood sample (arterial/mixed venous) 
and PxO2 = oxygen tension in the respective blood sample (arterial/mixed venous) and 0.0031 
represents the amount of CO2 dissolved in blood. 
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As the capillary content cannot be measured directly, it is estimated from an alveolar air 
equation.
 where Pb is the barometric pressure (torr) and 47 = barometric 
pressure of water (torr). RQ = respiratory quotient estimated 0.8.
Physiological dead space (VD/VT), ad modum Enghoff, representing the global V/Q mis-
match in the lungs was measured with PaCO2 (obtained via arterial blood gas) and volu-
metric capnography (NICO monitor, Respironics, Wallingford CT, USA) according to 
 where PaCO2 = systemic arterial pressure of carbon dioxide and PeCO2 = 
partial pressure of carbon dioxide in mixed expired air [86]. 
ABL-800FLEX (Radiometer Medical ApS, Brønshøj, Denmark) was used for blood gas 
analyses.
Data sampling and collection
In study I-III hemodynamic parameters were sampled into a data acquisition system 
(Acknowledge, version 3.2.7, Bio Pac Systems, Santa Barbara, CA, USA). 
In study IV, each measurement was photographed in real-time and transferred to a secure 
Breaths
Minutes
Minutes
Figure 7. Adapted screenshot of the data output from the experimental program. A schematic overview of the 
superimposed breathing pattern has been added for explanation (lower left corner). The red box represents the 9 
breaths being analyzed for that moment. With every new breath the box of nine breaths moves along and continu-
ously producing changes in FACO2 necessary for the capnodynamic calculations (see upper right corner). ELV and 
EPBF are continuously calculated below.
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server at the end of each case. All data from the Servo-i ventilator was automatically saved 
on a computer containing the capnodynamic program. Continuous data from the PiCCO2 
monitor was transferred to a secure server (available for 16 patients). Other data collected 
included preoperative patient characteristics, body mass index (BMI) and American Society 
of Anesthesiologists (ASA) class. Predictive body weight and body surface area were auto-
matically calculated by the PiCCO2. Operative information recorded included fluid boluses, 
blood transfusion requirements, intraoperative fluid balances and duration of surgery. Fluid 
balances were calculated by subtracting total output (urine output, blood loss, loss from 
drains and vomitus) from total input (all intravenous fluid intervention or parental medica-
tions). Third space losses were not included, as they were considered negligible. Mortality at 
30 days was recorded.
Experimental protocols
Study I
Baseline measurements of COTS, COEPBF, COPAC and COTPT were obtained at PEEP 5 cmH2O 
and a VT of 8 mL/kg. Hemodynamic and ventilatory parameters were then changed in the 
following order:
1) PEEP 0 cmH2O and 12 cmH2O.
2) Increased tidal volume from 8 to 12 mL/kg.
3) From BL conditions; preload reduction (50%) estimated by the COTS with controlled 
inflation of caval balloon.
4) Increase in PEEP from 5 to 12 cmH2O.
5) At PEEP 12; preload reduction (50%) estimated by the COTS by a controlled inflation 
of caval balloon.
6) PEEP decrease from 12 to 5 cmH2O.
7) From BL conditions; CO increase (150%) estimated by the COTS with dobutamine 
infusion.
8) Controlled bleeding titrated to a MAP target of 35 mmHg.
All measurements were performed at a steady state as estimated with the COTS. The animals 
were allowed to recover and stabilize between all interventions.
Study II
The protocol was twofold performed in separate group of animals. In the first part, eight 
animals, after routine precision and baseline (BL) measurements at FiO2 0.4, PEEP 5 cmH2O 
and VT of 8 mL/kg, an aortic balloon catheter was inflated, just beneath the diaphragm, until 
blood flow was attenuated in the contralateral femoral artery. At the end of the ischemia a new 
measurement was performed, and the balloon was released with a consequent reperfusion. 
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Figure 8. A schematic overview of the hemodynamic and ventilatory changes induced during study I. CO was 
calculated with the capnodynamic method (COEPBF), ultrasonic flow probe around the pulmonary trunk (COTS), 
pulmonary artery catheter (COPAC) and transpulmonary thermodilution (COTPTD). BL= Baseline, VT= Tidal Volume, 
PEEP= Positive End-Expiratory Pressure, CAVA= inflation of balloon in vena. CAVA, Dob= Dobutamine infusion.
Measurements with all three CO methods were performed at minute one, three and five and 
COEPBF and COTS additionally at minute two and four.
The second part of the protocol, performed in another eight animals, identical precision and 
baseline measurements were conducted as described before at FiO2 0.4, PEEP 5 cmH2O and 
VT 8ml/kg. At the airway opening, between the y-piece and carbon dioxide sensor, an exter-
nal dead space was added, aiming for 50-60% increase in PaCO2. Although not part of this 
published study, hypercapnia was additionally induced by lowering respiratory rate (with CO 
changes) and tidal volumes separately. These results have been published in an abstract form 
and are included in the results section [87].
Study III
At the start of the day, baseline measurement with healthy lungs (HL) was obtained as pre-
viously described. After the ischemia/reperfusion, the animals had time to recover before 
initiation of lung injury. After completed lung injury at FiO2 1.0 and PEEP 5 cmH2O, three 
baseline measurements were performed with CO changes (+/- 30%) in between (caval bal-
loon inflation and dobutamine infusion). Thereafter, a RM was performed and the level of 
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Figure 9. Schematic overview of the transient hypercapnia produced by inflating the aortic balloon catheter just 
beneath the diaphragm. BL= Baseline, R1-5= Reperfusion with measurements every minute for five minutes.
Figure 10. Schematic overview of the sustained hypercapnia induced with increased dead space at the y-piece. 
Measurements were obtained at baseline, after establishing a stable hypercapnia on average 44 (8) min later and 
at 7–12 min intervals between baseline and the interventions. Cardiac output manipulations with caval balloon 
inflation (CAVA) and dobutamine infusion (Dob) performed in between, aiming for ±30% change in CO. 
PEEP resulting in maximum dynamic compliance was considered the closing pressure. PEEP 
was set at 2-3 cmH2O higher than the closing pressure. The procedure lasted for 22 ±14 min-
utes and resulted in a PEEP range of 11-17 cmH2O.
Study IV
In the first 25 patients (CONP5) COEPBF and COTPTD measurements were performed (1) on 
three successive occasions at PEEP 5 cmH2O (baseline – BL 1-3), (2) 1-2 minutes after change 
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to PEEP 15 cmH2O, (3) 1-2 minutes after return to PEEP 5 cmH2O, (4) before epidural acti-
vation (pre-EDA) at PEEP 5 cmH2O and (5) 10 to 15 minutes later after epidural activation 
(EDA). The protocol was interrupted in six patients in the CONP5 group at the discretion 
of the attending anesthesia team, either to give volume bolus or start dobutamine infusion. 
These patients were not included in the event line per se, however in the Bland-Altman anal-
ysis, and 4Q plot. 
In the last ten included patients (CONPadj), compliance based RM was performed before ini-
tiation of the study protocol. In pressure control mode, inspiratory pressure (Pinsp) and PEEP 
were raised and reduced in a stepwise manner and the level of PEEP resulting in maximum 
dynamic compliance at the desired VT was considered the closing pressure. PEEP was then 
set at 1-2 cmH2O higher than the closing pressure and the ventilatory mode was changed back 
to volume controlled. Measurements were then performed in the same order as described 
above in the CONP5 group with one exception; in the PEEP step, 10 cmH2O was instanta-
neously added to the adjusted PEEP and then reduced again to the adjusted level.
During the surgical procedure, the attending anesthesiologist, routinely assessed if fluid 
optimization was indicated, based on an institutional algorithm for ODM (CardioQ), before 
and during surgery. If suitable, measurements were performed, as described above before and 
after fluid infusion. In case of hemorrhage or low cardiac output (CI < 2.5 L/min/m2), if hemo-
dynamically stable, measurements were performed before and after instillation of treatment. 
The attending anaesthesiologist chose the dose and type of local anaesthetic used (100-160 mg 
mepivacaine in all except two cases) for the epidural activation and could at any time change the 
order of the steps in the protocol if fluid optimization or dobutamine was indicated. 
Figure 11. Schematic overview of study III. Lung injury commenced and simultaneous measurements with both 
the capnodynamic method (COEPBF) and the ultrasonic flow probe (COTS) performed before and after RM and PEEP 
adjustment and CO changes. BL= Baseline, HL= Healthy Lungs, LI= Lung injury, CAVA= inflation of caval balloon, 
Dob= Dobutamine infusion, PEEP= Positive End-Expiratory Pressure, RM= Recruitment Manoeuvre, FiO2= fraction 
of inspired oxygen 
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Figure 12. Schematic overview of the first 25 patients in study IV (CONP5). Cardiac output was measured with the 
capnodynamic method (COEPBF) and transpulmonary thermodilution (COTPTD) at baseline 1 to 3 (BL 1-3), before and 
after changes in PEEP (P15 and back to P5) and epidural activation (pre EDA and EDA). During surgery events were 
captured (volume- and cardiac output optimization) with measurements before and after instillation of treatment 
(Pre VOL= before volume bolus, VOL = after volume bolus, Pre DOB= before dobutamine infusion, DOB= after 
dobutamine infusion. CVC= Central Vein Catheter.
Figure 13. Schematic overview of the last 10 patients in study IV (CONPadj). Recruitment manoeuvre was performed 
and PEEP individually adjusted before start of the protocol. Cardiac output was measured with the capnodynamic 
method (COEPBF) and transpulmonary thermodilution (COTPTD) at baseline 1 to 3 (BL 1-3), before and after changes 
in PEEP (P+10 and -10 cmH2O) and epidural activation (pre EDA and EDA). During surgery events were captured 
(volume- and cardiac output optimization) with measurements before and after instillation of treatment (Pre VOL= 
before volume bolus, VOL = after Volume bolus, Pre DOB= before dobutamine infusion, DOB= after dobutamine 
infusion. 
Statistics
The statistical methods applied in this thesis are discussed in the background section and are 
described in each paper.
The reliability of a statistical test is dependent on the sample size. In animal studies there 
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is a compromise between ethical and economical reasoning to use as few animals as possible 
but also accomplish statistical reliability. Although sample size calculations would have been 
possible based on data from the original capnodynamic method with inspiratory holds, i.e. 
with regards to precision, it was considered insufficient since they were tested during different 
conditions. Our previous animal studies were performed in 8-10 animals provided realistic 
evaluation of the new method against a highly accurate and precise reference method. 
In the human study, ten patients were added to the study after data analysis of the first 25 
patients. Of logistical reasons, recruiting more patients to the study was impossible. 
Normality and distribution of data was checked with D´Agostino and Pearson omnibus 
K2 test for all studies and presented as mean (SD) or median (range) as appropriate. Pro-
portional bias, i.e. the spread at different CO values was checked with linear regression and 
visual assessment. Pearson´s correlation coefficients were used to examine the relationship 
between shunt and bias (study III). Unpaired t-test was used to compare mean of two groups 
(study IV) with adjustments (Mann-Whitney) when assumption of normality was violated. A 
p-value <0.05 was considered statistically significant.
Inherent precision
In the animal studies, inherent precision of COEPBF (study I-III) and COTS (study II and III) 
was calculated as twice the coefficient of variation (CV = SD/meanCO) from 10 repeated 
measurements obtained at 1 min intervals in each animal at baseline conditions. In study 
IV the precision of COEPBF was calculated from six baseline values as described above. For 
COTPTD, CV was calculated from total three triplicates (9 thermodilutions) as SDTPTD/sqrt (3)/
mean COTPTD. The previously reported inherent precision for COTS was ±10% and for TPTD 
6-12% [82,88]. 
Agreement
As described, Bland-Altman plots were used to calculate the mean bias between the COEPBF 
and the reference methods. Limits of agreement (LoA) were calculated differently between 
studies to adapt to current guidelines when validating new CO methods [89]. In study II 
and III, a t-table was introduced to account for the small sample size. In case of only few 
measurements as during certain conditions a t-value was used, corresponding to the degrees 
of freedom and a type I error (α) of 0.05. As an example, for eight measurements the tα was 
2.365 instead of 1.96 when calculating the LoA. Corresponding t-value was used to calculate 
percentage error and confidence intervals. 
In study IV however, we used 1.96 for more righteous comparison to other CO methods as 
it appears to be exclusively used in clinical studies and meta-analysis.
A priori percentage error was set at equal or less than 30% to indicate if the two methods 
were interchangeable [72]. 
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Trending ability
The ability to track changes in CO was calculated with 4Q and polar plots describing the 
proportion and magnitude of measurements that change in the same direction. In study I-III 
and IV, an exclusion zone of 10 and 15% was used, respectively, with regards to the inherent 
precision of the reference methods and the calculated LSC. In study IV the calculated inher-
ent precision for the both methods was ~11%, and therefore the LSC~15%. 
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Results
Study I
Inherent precision of COEPBF was ±14. The different hemodynamic and ventilatory alterations 
produced large changes in CO. All animals survived the interventions.
Figure 14. Changes in mean (SD) cardiac output (L/min – left y-axis) measured with the capnodynamic method 
(COEPBF, blue line) and the ultrasonic flow probe (COTS, red line) during different interventions (x-axis). BL= Baseline, 
VT= Tidal volume, PEEP= Positive end-expiratory pressure, CAVA= inflation of balloon in v. CAVA, Dob= Dobuta-
mine infusion.
Figure 15. A trace from one animal representing the change and the response time after inflation and deflation of 
the caval balloon. Time to fully capture the change was approximately 19 seconds or 9 breaths (Respiratory Rate 
= 28 breaths/min).
rate for 55 paired delta values as assessed by the four-
quadrant and polar plot methodology was 96 and 92 %
respectively. The mean polar angle was -8.1 (95 % CI 4.7
to -11.4).
For COTDT the overall bias (LoA) and percentage error
was 0.5 (-0.4 to 1.5) L/min percentage error 29 %. The
concordance rate for 58 paired delta values analysed by the
four-quadrant and polar plot methodology was 97 and
95 % respectively. The mean polar angle calculated by the
polar plot methodology was 1.8 (95 % CI -1.4 to 5.0).
4 Discussion
In the current study we have evaluated the continuous
capnodynamic methodology, COEPBF, using a modified
ventilatory pattern based on cyclic variations in end-expi-
ratory pauses, during significant changes in CO and ven-
tilatory settings. In parallel we have also evaluated two
thermo-dilution based methods for comparison. In this
experimental setting the overall agreement and precision
improved compared to our previous results when the ven-
tilatory pattern was based on cyclic reoccurring inspiratory
pauses [8]. Trending ability was preserved and no para-
doxical rise in COEPBF was detected in response to an
increased PEEP level.
In comparison with COPAC, COEPBF showed a lower
percentage error in all interventions except during high CO
states. COTPT displayed the lowest percentage error in all
groups except during high CO.
A ventilatory pattern including inspiratory pauses is
more likely to affect the pulmonary blood flow especially
in hypovolemic states and higher PEEP levels as it intro-
duced extended periods at maximal intrathoracic and air-
way pressures. Since the capnodynamic equation assumes
that the pulmonary perfusion is constant during a mea-
surement cycle, a pattern altering the pulmonary blood flow
could be assumed to impair the agreement of the method.
By the studied modification of the ventilatory pattern the
agreement of COEPBF improved when an increased PEEP
level of 12 cm H20 was used with a bias (LoA) and per-
centage error of 0.2 (-1.0 to 1.4) L/min and 41 %
Fig. 6 A polar plot displaying the 61 paired delta values displayed by
the capnodynamic method COEPBF (L/min) and the reference method
for cardiac output COTS (L/min) from all interventions including the
PEEP and tidal volume change and haemodynamic interventions. The
blue vertical line indicates the mean angular bias and the surrounding
blue lines the confidence intervals of the angle. An exclusion zone of
10 % was used
. 7 A typical esponse, from one a al, to inflation and deflation of the b lloon in th inferior cava v in is displayed. The y-axis displays the
reference method for cardiac outp t, the ultrasonic flow probe (COTS) and the capnodynamic metho (COEPBF). Time is plotted on the x- xis
J Clin Monit Comput (2017) 31:717–725 723
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The agreement and concordance of COEPBF, COPAC and COTPT compared to COTS is shown in 
table 2. 
The overall performance was on level with the thermodilution methods, superior to theCOPAC 
and inferior to COTPT.
Study II
The inherent precision at baseline conditions were 8, 4 and 10% for COEPBF, COTS and COPAC, 
respectively. After 30 minutes of caudal ischemia, the balloon was released followed by a 
significant reperfusion and transient hypercapnia, temporarily affecting the performance of 
COEPBF when compared to COTS (see figure 16).
Table	2.	The results from Bland-Altman analyses for COEPBF, COPAC, COTPT when compared to the COTS, respectively. 
The results are divided into overall performance, different PEEP levels and high and low CO. 4Q = Four-Quadrant 
Plot; PP = Polar Plot; LoA= Level of Agreement; PE= Percentage Error.
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Figure 16. Timeline showing a mean (SD) values for COEPBF, COTS and COPAC from baseline (BL) to end of ischemia 
(EOI) approximately 30 min later and every minute for five minutes after reperfusion (COPAC only at 1, 3 and 5 min), 
and b continuous values from one animal for COEPBF and COTS (not possible with COPAC) starting 2 min before bal-
loon release (vertical broken line) and up to 8 min after reperfusion.
During sustained hypercapnia, induced with different ventilatory changes, the overall agree-
ment of COEPBF and COTS was similar to baseline performance, except in the low respiratory 
rate (RR) group where the bias was increased. Trending ability during both increased dead 
space ventilation and low RR was good in these eight animals (see table 3 and figure 17).
Study III
Two animals were excluded from the data analysis. In one animal, measurements after lung 
injury were unattainable because of cardiorespiratory instability. A computer failure made 
COEPBF data retrieval impossible in another animal. 
The calculated inherent precision of COEPBF and COTS was 9 and 6% at baseline conditions.
Induced lung injury caused respiratory failure including; elevated shunt, increased physi-
ological dead space and lowered PaO2/FiO2 ratio, as expected. Hemodynamic manipulations 
Figure 17. Four-quadrant plot for 32 
paired values of ΔCOEPBF and ΔCOTS 
during caval balloon inflation (ΔCOCAVA) 
and dobutamine infusion (ΔCODOB) at 
sustained hypercapnia (increased dead 
space and low respiratory rate). All 
values were outside of exclusion zone 
(10%).
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at these different conditions resulted in large changes in CO. COEPBF consequently underesti-
mated COTS at high shunt fractions (mean bias -0.6 L/min) and overestimated after RM and 
PEEP adjustment (mean bias 1.1 L/min) (see figure 18).
Percentage error during LI, both before and after was the same (40%) and comparable to 
baseline levels. Trending ability was 87% during high shunt fractions and 100% after RM and 
PEEP adjustment according to the 4Q-plot. The polar plot showed a mean angle -14.8° and 
radial limits of -40.0° to -10.5° at high shunt fractions and 2.3° and -22.9 to 18.3 after RM and 
PEEP adjustment.
Table	 3. Bland Altman data for 
sustained hypercapnia. The 
bias was increased in the low 
RR group, without affecting 
precision. NC= Normocapnia, 
HC= Hypecapnia, RR= Respi-
ratory Rate, CAVA= inflation of 
caval balloon, DOB= infusion of 
dobutamine, TV= Tidal Volume, 
DS= Dead Space, ME= Mean 
Error (same as percentage error), 
LoA= limits of Agreement.
Figure 18. Time line showing mean values and standard deviation for COEPBF, COTS (left y-axis, L/min) and shunt 
fraction (right y-axis) during lung injury (LI), before and after recruitment manoeuvre (RM) and PEEP adjustment 
(adj). Cardiac output changes were induced with caval balloon inflation (CAVA) and dobutamine infusion (Dob) 
during both conditions.
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Figure 19. Four-quadrant plot showing 15 paired values of ΔCOEPBF and ΔCOTS during cava balloon inflation (ΔCO-
CAVA) and dobutamine infusion (ΔCODOB) at both high shunt fraction and after recruitment manoeuvre and PEEP 
adjustment. All values were outside of the exclusion zone (10%).
Study IV
In total, 35 patients were included in the study and produced 329 paired values; thereof 234 
in the first 25 patients (CONP5) where all patients started equally at PEEP 5 cmH2O and 95 in 
the last 10 patients (CONPadj) where a lung RM and PEEP adjustment was performed before 
initiating the protocol. 
Inherent precision calculated for COEPBF and COTPTD at baseline conditions was 10 and 11% 
in CONP5 and 11 and 9% in CONPadj, respectively. There were no differences in demogra-
phy or factors related to the operation between the groups. Mean COEPBF and COTPTD for all 
35 patients was 4.7 and 4.8 L/min, respectively. There was no significant difference between 
COEPBF and COTPTD within each group 4.6 vs 4.8 L/min (p=0.06) in CONP5 and 4.9 vs 5.0 L/
min (p=0.2) in CONPadj). Changes in PEEP and activation of epidural analgesia all produced 
Figure 20. Event line displaying 
cardiac output measured with the 
capnodynamic method (COEPBF) 
and transpulmonary thermodilu-
tion (COTPTD) for total 30 patients 
from both groups (CONP5 and 
CONPadj). Data for five patients 
was excluded from the graph (all 
from the CONP5 group) as the 
steps were performed in different 
order. BL= Baseline, ΔPEEP↑ (+ 
10cmH2O) and ΔPEEP ↓(-10cm-
H2O), Pre EDA= Before epidural 
activation, Post EDA= After epi-
dural activation.
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significant changes in CO (see figure 20 for event line).
The CONPadj group, with individual compliance-based 
lung recruitment before protocol start had smaller bias, 
narrower LoA and lower PE compared to the CONP5 
group who all had PEEP 5 cmH2O from start. Two clinical 
outliers (118 and 98 kg with predominant abdominal fat) 
were identified in the CONP5 group with mean bias -2.1 
(1.0) and -1.9 (0.7) L/min, respectively. When excluded 
from the CONP5 group, changes in bias, LoA and PE were 
observed for the remaining 23 patients (CON2excl). See 
table 4 for comparison between the groups.
A few episodes of hemorrhage were captured with the 
continuous COEPBF monitoring and continuous pulse 
contour CO monitoring via the PiCCO2 monitor in indi-
vidual patients during the course of surgery (see figure 22 
for example).
One patient developed a small dissection in the axillary 
artery with acute arterial thrombosis partially occluding 
the peripheral flow, after removal of the thermistor tipped 
catheter. The patient had full recovery after conservative 
anticoagulation treatment.
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Figure 21. Four-quadrant plots for CONP5 
(A) showing 96 paired delta values and 
CONPadj (B) showing 41 paired delta values 
displayed by the capnodynamic method 
(COEPBF) and transpulmonary thermodilution 
(COTPTD) from all interventions. ∆PEEP 15 
(purple dots) = increase in PEEP from 5 to 
15 cmH2O; ∆PEEP 5 (blue squares) = de-
crease in PEEP from 15 to 5 cm H2O; ∆EDA 
(green triangle up) = before and after epidur-
al activation with 10-15 minutes apart; ∆Vol-
ume (orange triangle down) = before and 
after volume bolus; ∆Dob (black rhomboid) 
= before and after dobutamine infusion.
Figure 22. A continuous trace of various hemodynamic parameters from one patient with a sudden blood loss 
(600ml) from a large pelvic artery and an ongoing resuscitation with fluids (Ringer acetate and 20% Albumin) and 
increase in noradrenaline (0.06 to 0.12 µg/kg/min). Mean arterial pressure (MAP, pink line) was measured in the 
femoral artery from the thermistor-tipped catheter. Red dots indicate single transpulmonary thermodilution mea-
surements (COTPTD) and the largest red dot is the average of three preceding measurements; COPC (green line) = CO 
derived from the PiCCO pulse contour analysis. COEPBF (blue line) CO estimated with the capnodynamic method. 
HR (orange line) = heart rate. 
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Discussion
In this thesis we have evaluated the revised capnodynamic method with expiratory holds for 
CO estimation. In a variety of clinically relevant and challenging situations both in a large 
animal model and patients undergoing high risk abdominal cancer surgery, the capnody-
namic method was compared to the best available and acceptable reference methods. For this 
purpose, we used study designs and statistical methods that are considered current practice.
The principal findings are:
The capnodynamic method showed overall good performance, comparable to the ther-
modilution methods when altogether compared to the ultrasonic flow probe during various 
hemodynamic and ventilatory changes in a large animal model. 
The performance remained good during sustained hypercapnia in a large animal model, but 
as expected, temporarily disrupted during the transient large change in mixed venous CO2 
content following reperfusion. Somewhat surprisingly, the method quickly adapted to a new 
steady state within five minutes. 
During lung injury and respiratory failure, the capnodynamic method slightly underes-
timated CO at high shunt fractions and unexpectedly overestimated CO after recruitment 
and PEEP adjustment. Precision and trending ability were maintained despite these extreme 
conditions. 
Evaluated for the first time in major abdominal cancer surgery, the capnodynamic method 
showed overall good performance, with further improvement after individualized RM and 
PEEP adjustment.
Aspects on the experimental model
During high risk surgery hemodynamic changes are to be expected and as clinicians we wish 
to respond in real time based on accurate continuous information. Animal studies provide us 
with great possibilities to induce physiological changes and compare one or more methods 
to a highly accurate reference method, which is unattainable and unethical in humans. For 
the evaluation of the capnodynamic method we chose large animals (porcine) 32-44 kg with 
comparable hemodynamic and respiratory physiology. However, possible differences in CO2 
metabolism between species i.e. due to higher baseline core temperature are unaccounted for 
as well as congenital heart and lung defects in the individual animal.
In the caudal ischemia model we wanted to simulate high risk aortic surgery with sub-
sequent reperfusion. Severe hemodynamic and metabolic changes were observed that were 
partially attenuated with pharmacological support to keep the animals alive. Despite inter-in-
dividual differences, all animals had an instantaneous rise in PvCO2 and PaCO2 and significant 
hemodynamic changes as intended. Sustained hypercapnia (PvCO2 >10 kPa), occasionally 
seen clinically (i.e. laparoscopy), was induced by three different approaches without affecting 
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precision or trending ability. The positive bias seen at low RR was significantly different from 
the other two (increased dead space and low TV) which raised suspicion of recirculation, 
although this could not be confirmed with serial blood gases.
The lung injury model with lavage induced surfactant depletion is commonly employed in 
animal studies to replicate respiratory failure [90]. We added VILI to the model to limit the 
reversibility of the lavage-induced injury after lung recruitment and PEEP adjustment, for 
stronger clinical correlation. There were also inter-individual differences in this model and 
therefore both these models are relatively heterogeneous. However, the main objective was to 
challenge the capnodynamic method in situations where limitations are to be expected in a 
CO2-based method, and not to produce a perfect model per se. It is important nonetheless to 
keep in mind that animal studies can only serve as a model for human physiology and results 
cannot be directly transferred to clinical practice.
Aspects on the clinical study
In total 35 patients, undergoing high risk open abdominal cancer surgery, motivating invasive 
transpulmonary thermodilution, were included in the study after informed consent. Standard 
clinical procedures, such as minor PEEP changes and epidural activation were formalized 
in a protocol. Other intraoperative events where hemodynamic changes were expected (i.e. 
volume bolus and dobutamine infusion when clinically indicated) were captured with mea-
surements performed before and after installation of treatment. In 75% of the patients the 
change in CO was >15% in either method creating total 96 paired delta values with 90-92% 
concordance. In this heterogeneous surgical population, inter-individual differences were 
also noticed, particularly in the +PEEP step where we, frequently observed an initial rise in 
COEPBF when PEEP was increased, preceding the anticipated drop due to elevated intratho-
racic pressure compromising venous return. This could possibly be explained by the initial 
alveolar recruitment and CO2 being squeezed into the alveoli. No objective measurements 
of atelectasis, shunt or dead space were performed. Despite the fact that COEPBF calculates 
another physiological entity, the mean CO of the two methods was essentially the same for 
all measurements. The small negative total bias observed, was expected, as COEPBF does not 
account for the shunted blood flow. 
Transpulmonary thermodilution as a reference method
The transpulmonary thermodilution was chosen as a reference due to good reported inherent 
precision and familiarity with its use. The measured inherent precision at baseline conditions 
was approximately 10%. However, in 10% of the triplicates performed, a >15% difference 
between individual thermodilutions was observed. A possible explanation could be that a 
steady state was not fully accomplished when the thermodilution process was started. In these 
cases we added one or two thermodilutions and excluded the diverted one to regain accuracy. 
COEPBF measurements were registered when the first thermodilution started and the last one 
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ended. This could be considered a strength to the study, i.e. that each paired measurement 
represents the measured period as accurately as possible. However, it also reinforces the argu-
ment discussed in the background that the thermodilution methods lose their inherent preci-
sion during hemodynamic changes and therefore challenges the validity of the 30% cut-off in 
percentage error commonly used as a priori. 
Only high risk surgery patients scheduled for a central vein catheter were included in the 
study. Addition arterial catheter was added for invasive CO monitoring and more precise 
perioperative hemodynamic guidance. Temporary arterial occlusion is a rare complication 
after insertion of arterial catheter in the femoral or axillary artery (1.2-1.5%) [91]. However it 
was a reminder that all interventions convey risk and all the more reason to develop non-in-
vasive alternatives that can perform well in the operation theatre. 
The capnodynamic method in challenging situations
An important feature of a hemodynamic monitor is reliability and trending ability in criti-
cal situations. The objective of this thesis was therefore to expose the revised capnodynamic 
method to challenging situations to reveal both strengths and limitations. The capnodynamic 
method calculates non-shunted CO and thereby estimates CO based on the changes in alveo-
lar CO2. The calculations are based on physiological and mathematical principles; thus some 
assumptions are inevitable for the non-invasive function. One of these assumptions is that the 
content of mixed venous CO2 must be in a steady state when measurements are performed. 
Historically this has been a major limitation to all CO2 based methods. The capnodynamic 
method however, with its superimposed breathing pattern, automatically recalibrates itself 
and quickly re-establishes a new steady state, continuously correcting for sources of error. 
This is evident from our animal studies; the fast response time to hemodynamic changes 
and overall good agreement in different challenging hemodynamic and ventilatory situations, 
observed in study I [92]; the resilience after major reperfusion, restoring the function within 
five minutes and unaffected agreement during sustained hypercapnia, as observed in study II 
[93]; and maintained precision and trending ability during lung injury, as observed in study 
III. 
Shunt correction or lung optimization?
It is obvious that conditions that increase the shunt flow will influence the accuracy of all 
CO2-based methods. Both the semi continuous rebreathing method (NICO®) which is the 
only clinically available CO2 based method up to now and the continuous Capnotracking 
method currently under clinical development by Peyton et al in Australia, have shunt correc-
tions included [59,60]. Shunt correction could easily be incorporated into the capnodynamic 
equation, however, the capnodynamic method has qualities that might be utilized in diverse 
clinical situations as it estimates the non-shunted CO. Perhaps instead of correcting for shunt, 
we should focus on reducing shunt with individualized respiratory optimization. In modern 
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anesthesia management, lung recruitment and PEEP adjustment are commonly performed 
to counteract the effect of anesthesia on lung function, which per se, can cause atelectasis and 
further develop into postoperative pulmonary complications [94]. These effects are commonly 
magnified by other factors such as obesities, increased intraabdominal pressure (laparoscopy) 
and different body positions (i.e. Trendelenburg, prone), emphasizing the importance of per-
sonalized respiratory treatment [95-97]. 
The results from our clinical study (study IV) when compared to the other CO2 based 
methods indicate that shunt correction may not be needed. In fact, the overall agreement 
in patients with VT 6-8ml/kg and PEEP 5 cmH2O might be considered clinically acceptable 
considering the good trending ability. In the CONP5 group, we observed two clinical outliers 
who had by far the largest negative bias. They were both obese with predominant abdomi-
nal fat, where lung recruitment and PEEP adjustment would clinically been indicated. When 
they were excluded from the Bland-Altman analysis the PE decreased by 5% (41 to 34%). In 
light of these results and current anesthesia management we added 10 patients where we, 
with a simple lung recruitment and PEEP adjustment, tried to individualize the respiratory 
treatment. We had no objective measure of shunt or atelectasis before or after the procedure. 
Although not statistically significant, PE error was reduced from 41 to 31%, when RM and 
PEEP adjustment were performed before starting the study protocol. 
In the animal study, severe respiratory failure was induced with lung injury causing high 
shunt fraction, hypoxemia and increased driving pressure. As expected, bias increased, how-
ever, precision and trending ability were mostly unaffected. After recruitment and PEEP 
adjustment, the shunt was reversed. COEPBF overestimated the CO by ca 30%, however there 
was no correlation between the PEEP level and bias per se in these animals, as previously 
observed at high PEEP levels in animals with healthy lungs (data not shown). This overesti-
mation was not observed in the clinical study.
This could be valuable when the deteriorating patient arrives in the ICU and needs emer-
gency airway and breathing management. With physiological understanding and clinical 
skills, the method, either solely or in combination with i.e. echocardiography, could possibly 
guide resuscitation and PEEP titration for optimal oxygen delivery instead of relying entirely 
on compliance and PaO2:FiO2 ratio. 
Interpretation of performance
The term “agreement” encompasses both accuracy (bias) and precision (LoA and PE). 
Although interrelated, the tracking ability is a measure of a concordance after a change and 
reported separately. Forced to choose between agreement and trending ability, as an anesthe-
siologist, I would prefer to know if CO drops suddenly by 15% during surgery rather than if 
the CO is exactly 5.0 or 6.0 L/min in a steady state. 
In study I-III, the capnodynamic method showed a small positive bias (overestimation) at 
baseline conditions, not observed in the clinical study. Accuracy was interrupted in situations 
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where one would expect, during transient change in mixed venous content of CO2 and at high 
shunt fraction. The positive bias observed at high airway pressures after lung recruitment 
and PEEP adjustment in the animal study was not detected in healthy lungs after a related 
procedure in the clinical study. 
The precision in the animal studies was in the range of 28-42%, aside from the reperfusion. 
In study II and III we used more stringent criteria for calculations of percentage error to 
account for the small sample size. In study IV, the group who received individualized respira-
tory treatment had PE from 20 to 39% (mean 31%) and patients who received PEEP 5 cmH2O 
had PE from 34 to 42% (mean 41%).
The trending ability was >90% according to both 4Q- and polar plots during all CO changes 
except during at high shunt fraction in study III. However, the CO changes induced in the 
animal model are large >30% and one might expect good concordance in such experiments. 
In clinical situations (study IV), the change in CO was >15% in 3 out of 4 paired values and 
the concordance 92% for the whole group. For volume bolus the concordance was 100%, 
although there was a large difference in the variation of the change. 
In this thesis, we use the word “acceptable” to describe agreement. This is based on an overall 
good accuracy, (except for the special conditions described above) and a PE above the priori 
(30%) but within 45%. Considering that some difference is expected as the methods represent 
different entities, we believe that “acceptable” is entitled. Trending ability was good (90%) 
throughout the studies (with one exception) and in some conditions excellent. All qualities 
accounted for, we considered the overall performance of the capnodynamic method as good. 
Strengths and possibilities
The capnodynamic method has many qualities as a CO monitor, which would be desired by 
clinicians. It provides continuous relatively accurate and reproducible estimates of CO and 
reliably corresponds to changes thereof in real time. According to our current and previous 
studies and observations it is unaffected by changes in arterial resistance or heart rhythm. 
The method is non-invasive, in the sense that it requires controlled mechanical ventilation, 
which is common practice during high risk surgery. It is easy to use and runs automatically, 
providing breath by breath values within a couple of minutes. It could be turned on and off 
at the discretion of the anesthesia team and used in combination with other monitoring. As 
a unique physiological entity, it could theoretically be used for PEEP titration for optimal 
oxygen delivery as COEPBF will fall when the increased airway pressure constrains the venous 
return. 
In addition, the capnodynamic method provides calculations of the ELV, closely related to 
the FRC, although considered to be a functional volume more than an anatomical one. There 
are ongoing studies describing ELV functionality in relation to end expiratory lung volume 
(EELV) and functional residual capacity (FRC).
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Limitations
There are important limitations to the capnodynamic method that need to be addressed. The 
capnodynamic method is still only available as a research module and requires a mainstream 
volumetric capnometer. It requires a controlled mechanical ventilation, almost exclusively 
conducted under general anesthesia or intensive care. It has not been validated with inhaled 
anesthetic drugs and has only been studied with intravenous anesthesia. The method does 
not account for shunted blood flow and RM and PEEP adjustment are advised for better V/Q 
match and optimal performance, especially in overweight patients. The method has not been 
tested in patients with respiratory failure or BMI > 35 kg/m2. 
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Future perspectives
The results from extensive animal studies and the clinical pilot study during high risk abdom-
inal surgery are encouraging and with great potential. A precise continuous monitoring of the 
effective pulmonary blood flow, estimating CO, could be valuable for the individual patient, 
providing real time feedback to guide treatment (fluids, vasopressors, inotropy and PEEP). 
However, no method will improve outcome unless coupled to a treatment strategy. One 
possibility would be to optimize COEPBF in a goal directed fashion with fluids (+/- inotropy) 
and PEEP combined with clear (personalized) blood pressure targets. An interesting feature 
would be to connect the breathing pattern to variations in pulse pressure and stroke volume. 
With the emergence of artificial intelligence and machine learning one can be indulged 
by the thought of a futurized fully automated monitoring station. An algorithm combining 
flow (i.e. via COEPBF), continuous (non-invasive) blood pressure, dynamic parameters (such 
as variation in stroke volume and pulse pressure) and depth of anesthesia (i.e. MAC values 
or bispectral index) and perhaps an objective estimation of the microcirculation to navigate 
a patient through a demanding surgery, with a skilled anesthesia team ready to act in case of 
(predicted) crisis. 
The next logical step for the capnodynamic method is to integrate the software into the 
modern anesthesia machine with a user-friendly interface. Further development to allow par-
allel use of halogenated anesthetic gases is a priority and would facilitate further feasibility- 
and validation studies in other surgical populations, i.e. emergency surgery, head and neck 
surgery, neurosurgery and complex spine surgery where access to the patient during surgery 
is often limited. 
In the intensive care unit, it would be interesting to test COEPBF in patients with respiratory 
failure, in whom invasive hemodynamic monitoring is already applied. Perhaps PEEP titra-
tion based on COEPBF versus the standard compliance/PaO2:FiO2 based recruitment could be 
favourable in terms of oxygen delivery and right ventricular strain. 
Parallel to this project, in collaboration with the Royal Institute of Technology, a develop-
ment of a nano-CO2 sensor is underway that could provide highly accurate volumetric assess-
ment of CO2 without any further equipment or cables. Integrated into the y-piece or endo-
tracheal tube it could seamlessly transmit information wirelessly to the anesthesia machine.
The capnodynamic method has a unique potential. With over 300 million operations per-
formed worldwide each year, including a large part in general anesthesia with mechanical 
ventilation, a flow based method like COEPBF integrated into the anesthesia machine at low 
cost with well-defined hemodynamic targets could have a large impact on outcome. 
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Conclusions
In summary, we have evaluated the revised capnodynamic method (COEPBF) with expira-
tory holds, for cardiac output estimation. COEPBF was compared to an ultrasonic flow probe 
mounted on the pulmonary trunc during various hemodynamic and respiratory challenges 
in a large animal model and to a transpulmonary thermodilution in patients undergoing high 
risk abdominal cancer surgery. 
Overall, COEPBF showed acceptable agreement and precision during a range of hemody-
namic and respiratory situations and good trending ability, in both large animal models and 
during high risk abdominal cancer surgery.
In a large animal model
1. COEPBF showed acceptable agreement and precision at different cardiac outputs, tidal 
volumes and PEEP in healthy lungs compared to an experimental gold standard ref-
erence method. After induced changes in cardiac output, the response time was fast 
and trending ability good.
2. COEPBF agreement was disrupted during transient large change in mixed venous CO2 
content, however restored within five minutes. The overall agreement and trending 
ability were maintained during sustained elevation of mixed venous CO2 content.
3. COEPBF accuracy was marginally affected during severe lung injury, both at high shunt 
fractions and after compliance based lung recruitment. Precision was maintained 
during both conditions and trending ability was acceptable at high shunt fractions 
and excellent after lung recruitment. 
In high risk abdominal surgery
4. COEPBF showed acceptable agreement and precision compared to a transpulmonary 
thermodilution measured cardiac output. Trending ability was good during a variety 
of clinically relevant hemodynamic changes. 

57
Performance of a revised capnodynamic method for cardiac output monitoring
Acknowledgement
Håkan Björne, main supervisor and commander in chief of KARISMA, a.k.a Big Björne a.k.a 
Sugar Daddy. So grateful that you trusted me with this project. Feels like yesterday when our 
eyes met in the dressing room. Iceland, Hong Kong, London, Milan, Geneva and LeBroc. 
What a ride! Despite tough last couple of months, you always manage to see the bright side 
and push me forward. Besides being brilliant you are a genuinely nice guy and there are some 
things I´ve learned from you unrelated to this project that will be even more valuable to me 
in the long run. 
Caroline Hällsjö-Sander, my co supervisor, KARISMA next in charge, and my personal lan-
guage coach. A woman with a plan. Born to be chef (works in both languages). Thank you 
for believing in me and giving me the best jumpstart! Watching you do a thoracotomy was 
something special. Loved your companionship through our travels and some heavy drinks. 
All things considered you stand for many crucial moments in this project. 
Anders Oldner my co-supervisor. My respect for you has no boundaries! Your magic touch is 
truly magic. Valuable feedback on demand and generous praise when truly earnt. Ten years of 
clinical drilling and now four years of research. You´ve had an impact on me.
Tomas Öhman, PhD brother in KARISMA and a great friend. Your sense of humor and love 
of life is truly contagious. A privilege to be on this journey with you. I´ve had so much fun 
during our travels together. I promise, I will be there for you!
Mats Wallin and Magnus Hallbäck for all the great discussions, feedback and mathematical 
assistance. I admire how you have managed and believed in this project when perhaps only a 
few have realized the true potential. 
Fernando Suarez Sipmann, your feedback has really made me a better researcher. Your per-
sistence and insight into the data has been very valuable to me. Your lung injuries and recruit-
ments are the best. Thank you!
Eider Redondo, for the lung injuries and fun time at Hedenstierna.
Marja Lindqvist, my clinical boss, colleague in KARISMA. Thanks for the all the support. 
What a fun Hong Kong was. We should do that again!
Anil Gupta, research colleague and manager of KARISMA. Second friendliest man in the 
world (after Ghandi). Always available. I admire how you run all your projects. Please don´t 
start watching Netflix.
Eddie Weitzberg, professor at PMI. Always smooth and composed. You always bring out the 
best in people. Thanks for all the last minute help! 
58
Thorir Sigmundsson
Lars I Ericsson, head of our research PMI research unit. Star struck when I met you and still 
am. You run our research unit with such class and dedication. Proud to be a part of it. Thank 
you for your support!
Kristina Hambraeus Jonzon, for hiring me at ANOPIVA/PMI and provide me with excellent 
resources to develop as a doctor. 
Eva Selldén, my former clinical boss. Thank you for your support and encouragement.
The Hemodynamic group at PMI
- Anna Ekman, anesthesia nurse. CONNIE´s best friend! Really enjoyed our early 
mornings together and excited about our future collaboration. You´re doing a fantas-
tic work!
- Josefin, Annika, Mia. Your enthusiasm brings energy to PMI!
Anna Schening and Anna Granström anesthesia research nurses. For your excellent care of 
all CONNIE´s. Your fine touch made CONNIE a better study. 
Funktion Open Abdomen. Big thanks to all the team at “Öppen buk” SSK, USK och LÄK 
who have helped me with CONNIE. I really appreciate it. Special thanks to Paola, Evelyn 
and Britt for taking good care of my stuff and Ann Karlsson and Susanne Wagmo for being 
especially supportive.
Hedenstierna laboratory, for all the great help with the animal studies. Special thanks to 
Agneta Rosenius and Anders Larsson for your fine support (at all altitudes).
All the great colleagues at PMI. For continuous stimulation and great support. You are the 
best! Olof Brattström, COYS! Thanks for being a great supporter and watching my back. Pet-
ter Westfelt, for bringing us all closer together with better communication. Fredrik Öberg for 
your help with CONNIE and all the great CVC discussions for the past years. Maria Nilsson, 
for being a good friend to CONNIE. Can´t wait to get back on the floor with you again. Anna 
Wennmo for great hospitality and fun time together, not to mention the partnership at BAS 
and “CVK skolan” Malin Jonsson Fagerlund, for your drive and enthusiasm. It´s inspiring! 
Peter Rudberg, for your excellent work, Henrik Jörnvall, for the extended “fadder”ship, Johan 
Nordström and Pierre Sundin for support and clinical discussions, Jessica Kåhlin for good 
advice and being the best during crazy on-calls together. 
Anna Tapper and Emma Hasselgren, colleagues and PhD students in KARISMA. Thank you 
for the friendship and fun times together, not to mention the “KORR” and the support. LeB-
roc was wonderful! Can´t wait for the next adventure! Exciting times ahead!
Peter Sackey, my supervisor during residency. For always being positive and supportive. 
Daniela Gordon, my resident adept. I think I´ve learnt more from you the last year than the 
other way around. Thank you for the pep!
59
Performance of a revised capnodynamic method for cardiac output monitoring
Ramis fixarna. Ten out of ten! Excellent work!
Árni Torfa, for lifesaving help with the layout!
My old team at SAk (Akureyri Teaching Hospital), Björn, Girish, Oddur, SES, Ásbjörn, 
 Helga and all the wonderful nurses for teaching me clinical skills. Special thanks to Björn for 
opening my eyes to research. 
„The Shark and Brennivín Club“, the Icelandic anesthesia association at Karolinska. Always 
fun to hang out with you! Although the day after can sometimes be tough. Pétur, thank you for 
the revision of the Icelandic abstract and the fine scheduling which allows me to do research 
and help with the Icelandic summary.  
Halla and Bjarni. Team anesthesia is currently winning the Economics at Partners. Just 
wanted that documented in my book  Thanks for all the fun and golf, not to mention the 
support.
The Stockholm family for making life more fun. Love spending time with you! We have some 
serious catching up and board games to do. 
My Icelandic family, Mom and Dad, Gauti and Eggert for providing the best possible 
upbringing and great support. 
My friends back home in Iceland, for your interest and loveliness. Let´s stay in touch! 
Gunnur og Steini, my in-laws. This would never have happened without your help through-
out the years. My deepest gratitude! Sandra, Sóley and Gunnur for being so extremely helpful 
with the boys and everything else. You´re the best!
Thorri, Elis, Axel, my three beautiful boys. Can´t wait to get back to normal routine for some 
snuggle and play time 
Hulda, congratulations on your own Psychological home Degree (PhD). Thank you for taking 
care of EVERYTHING for the last months and being the best support at the lowest moments. 
I love you for that and so much more!
This project is a collaboration between Karolinska Institutet and Maquet Critical Care AB. 
The work was supported by unrestricted grants from; (1) Maquet Critical Care AB, (2) the 
regional agreement on medical training and research (ALF) between Stockholm County 
Council and the Karolinska Institutet, (3) HMT project (Health, Medicine and Technology), 
a collaboration project between the Stockholm County Council and the Royal Institute of 
Technology and (4) VINNOVA, Sweden´s innovation agency.
And finally, my deepest gratitude to all the patients who, despite their illness, selflessly con-
tribute to and make clinical research possible
60
Thorir Sigmundsson
References
1. Shoemaker WC, Appel PL, Kram HB (1992) Role of oxygen debt in the development of 
organ failure sepsis, and death in high-risk surgical patients. Chest. 102 (1):208-215
2. Shoemaker WC, Patil R, Appel PL, Kram HB (1992) Hemodynamic and oxygen transport 
patterns for outcome prediction, therapeutic goals, and clinical algorithms to improve 
outcome. Feasibility of artificial intelligence to customize algorithms. Chest. 102 (5 Suppl 
2):617s-625s
3. Chong MA, Wang Y, Berbenetz NM, McConachie I (2018) Does goal-directed haemo-
dynamic and fluid therapy improve peri-operative outcomes?: A systematic review and 
meta-analysis. Eur J Anaesthesiol. 35 (7):469-483. doi:10.1097/eja.0000000000000778
4. Desborough JP (2000) The stress response to trauma and surgery. Br J Anaesth. 85 
(1):109-117
5. Carsetti A, Watson X, Cecconi M (2016) Haemodynamic coherence in perioperative set-
ting. Best Pract Res Clin Anaesthesiol. 30 (4):445-452. doi:10.1016/j.bpa.2016.10.007
6. Lobo SM, de Oliveira NE (2013) Clinical review: What are the best hemodynamic targets 
for noncardiac surgical patients? Crit Care. 17 (2):210. doi:10.1186/cc11861
7. Minto G, Biccard B (2014) Assessment of the high-risk perioperative patient. Continuing 
Education in Anaesthesia, Critical Care and Pain. 14 (1):12-17. doi:10.1093/bjaceaccp/
mkt020
8. Cecconi M, Corredor C, Arulkumaran N, Abuella G, Ball J, Grounds RM, Hamilton M, 
Rhodes A (2013) Clinical review: Goal-directed therapy-what is the evidence in surgical 
patients? The effect on different risk groups. Crit Care. 17 (2):209. doi:10.1186/cc11823
9. Weiser TG, Haynes AB, Molina G, Lipsitz SR, Esquivel MM, Uribe-Leitz T, Fu R, Azad 
T, Chao TE, Berry WR, Gawande AA (2015) Estimate of the global volume of surgery 
in 2012: an assessment supporting improved health outcomes. Lancet. 385 Suppl 2:S11. 
doi:10.1016/s0140-6736(15)60806-6
10. Pearse RM, Moreno RP, Bauer P, Pelosi P, Metnitz P, Spies C, Vallet B, Vincent JL, Hoeft 
A, Rhodes A, European Surgical Outcomes Study group for the Trials groups of the 
European Society of Intensive Care M, the European Society of A (2012) Mortality after 
surgery in Europe: a 7 day cohort study. Lancet. 380 (9847):1059-1065. doi:10.1016/
S0140-6736(12)61148-9
11. Global patient outcomes after elective surgery: prospective cohort study in 27 low-, mid-
dle- and high-income countries  (2016). Br J Anaesth. 117 (5):601-609. doi:10.1093/bja/
aew316
12. Bennett-Guerrero E, Welsby I, Dunn TJ, Young LR, Wahl TA, Diers TL, Phillips-Bute BG, 
Newman MF, Mythen MG (1999) The use of a postoperative morbidity survey to evalu-
ate patients with prolonged hospitalization after routine, moderate-risk, elective surgery. 
Anesth Analg. 89 (2):514-519
61
Performance of a revised capnodynamic method for cardiac output monitoring
13. Khuri SF, Henderson WG, DePalma RG, Mosca C, Healey NA, Kumbhani DJ, Partici-
pants in the VANSQIP (2005) Determinants of long-term survival after major surgery 
and the adverse effect of postoperative complications. Ann Surg. 242 (3):326-341; discus-
sion 341-323
14. Harper D, Chandler B (2015) Splanchnic circulation. BJA Education. 16 (2):66-71. 
doi:10.1093/bjaceaccp/mkv017
15. Grocott MP, Dushianthan A, Hamilton MA, Mythen MG, Harrison D, Rowan K (2013) 
Perioperative increase in global blood flow to explicit defined goals and outcomes after 
surgery: a Cochrane Systematic Review. Br J Anaesth. 111 (4):535-548. doi:10.1093/bja/
aet155
16. Hamilton MA, Cecconi M, Rhodes A (2011) A systematic review and meta-analysis on 
the use of preemptive hemodynamic intervention to improve postoperative outcomes in 
moderate and high-risk surgical patients. Anesth Analg. 112 (6):1392-1402. doi:10.1213/
ANE.0b013e3181eeaae5
17. Pestana D, Espinosa E, Eden A, Najera D, Collar L, Aldecoa C, Higuera E, Escribano S, 
Bystritski D, Pascual J, Fernandez-Garijo P, de Prada B, Muriel A, Pizov R (2014) Periop-
erative goal-directed hemodynamic optimization using noninvasive cardiac output mon-
itoring in major abdominal surgery: a prospective, randomized, multicenter, pragmatic 
trial: POEMAS Study (PeriOperative goal-directed thErapy in Major Abdominal Sur-
gery). Anesth Analg. 119 (3):579-587. doi:10.1213/ane.0000000000000295
18. Pearse RM, Harrison DA, MacDonald N, Gillies MA, Blunt M, Ackland G, Grocott MP, 
Ahern A, Griggs K, Scott R, Hinds C, Rowan K, Group OS (2014) Effect of a periop-
erative, cardiac output-guided hemodynamic therapy algorithm on outcomes following 
major gastrointestinal surgery: a randomized clinical trial and systematic review. JAMA. 
311 (21):2181-2190. doi:10.1001/jama.2014.5305
19. Rollins KE, Lobo DN (2016) Intraoperative Goal-directed Fluid Therapy in Elective 
Major Abdominal Surgery: A Meta-analysis of Randomized Controlled Trials. Ann Surg. 
263 (3):465-476. doi:10.1097/sla.0000000000001366
20. Ackland GL, Iqbal S, Paredes LG, Toner A, Lyness C, Jenkins N, Bodger P, Karmali S, 
Whittle J, Reyes A, Singer M, Hamilton M, Cecconi M, Pearse RM, Mallett SV, Omar 
RZ (2015) Individualised oxygen delivery targeted haemodynamic therapy in high-risk 
surgical patients: a multicentre, randomised, double-blind, controlled, mechanistic trial. 
Lancet Respir Med. 3 (1):33-41. doi:10.1016/s2213-2600(14)70205-x
21. Gomez-Izquierdo JC, Trainito A, Mirzakandov D, Stein BL, Liberman S, Charlebois P, 
Pecorelli N, Feldman LS, Carli F, Baldini G (2017) Goal-directed Fluid Therapy Does 
Not Reduce Primary Postoperative Ileus after Elective Laparoscopic Colorectal Sur-
gery: A Randomized Controlled Trial. Anesthesiology. 127 (1):36-49. doi:10.1097/
aln.0000000000001663
22. Sun Y, Chai F, Pan C, Romeiser JL, Gan TJ (2017) Effect of perioperative goal-directed 
62
Thorir Sigmundsson
hemodynamic therapy on postoperative recovery following major abdominal surgery-a 
systematic review and meta-analysis of randomized controlled trials. Crit Care. 21 (1):141. 
doi:10.1186/s13054-017-1728-8
23. Saugel B, Vincent JL, Wagner JY (2017) Personalized hemodynamic management. Cur-
rent opinion in critical care. 23 (4):334-341. doi:10.1097/mcc.0000000000000422
24. Saugel B, Reuter DA (2014) Use of hemodynamic algorithm after gastrointestinal surgery. 
JAMA. 312 (14):1469-1470. doi:10.1001/jama.2014.10363
25. Dalfino L, Giglio MT, Puntillo F, Marucci M, Brienza N (2011) Haemodynamic goal-di-
rected therapy and postoperative infections: earlier is better. A systematic review and 
meta-analysis. Crit Care. 15 (3):R154. doi:10.1186/cc10284
26. Saugel B, Michard F, Scheeren TWL (2018) Goal-directed therapy: hit early and person-
alize! J Clin Monit Comput. 32 (3):375-377. doi:10.1007/s10877-017-0043-x
27. Pinsky MR, Payen D (2005) Functional hemodynamic monitoring. Crit Care. 9 (6):566-
572. doi:10.1186/cc3927
28. Gurgel ST, do Nascimento P, Jr. (2011) Maintaining tissue perfusion in high-risk surgical 
patients: a systematic review of randomized clinical trials. Anesth Analg. 112 (6):1384-
1391. doi:10.1213/ANE.0b013e3182055384
29. Fick A (1870) Uber die Messung des Blutquantums in den Herzventrikeln. 
30. Vandam LD, Fox JA (1998) Adolf Fick (1829-1901), physiologist: a heritage for anesthesi-
ology and critical care medicine. Anesthesiology. 88 (2):514-518
31. Gedeon A (2006) Science and technology in medicine. Springer, 
32. Jaffe MB (1999) Partial CO2 rebreathing cardiac output--operating principles of the 
NICO system. J Clin Monit Comput. 15 (6):387-401
33. Laszlo G (2004) Respiratory measurements of cardiac output: from elegant idea to useful 
test. J Appl Physiol (1985). 96 (2):428-437. doi:10.1152/japplphysiol.01074.2001
34. Swan HJ, Ganz W, Forrester J, Marcus H, Diamond G, Chonette D (1970) Catheterization 
of the heart in man with use of a flow-directed balloon-tipped catheter. N Engl J Med. 283 
(9):447-451. doi:10.1056/nejm197008272830902
35. Stetz CW, Miller RG, Kelly GE, Raffin TA (1982) Reliability of the thermodilution method 
in the determination of cardiac output in clinical practice. Am Rev Respir Dis. 126 
(6):1001-1004
36. Marik PE (2013) Obituary: pulmonary artery catheter 1970 to 2013. Annals of intensive 
care. 3 (1):38. doi:10.1186/2110-5820-3-38
37. Pinsky MR, Vincent JL (2005) Let us use the pulmonary artery catheter correctly and only 
when we need it. Crit Care Med. 33 (5):1119-1122
38. Cecconi M, De Backer D, Antonelli M, Beale R, Bakker J, Hofer C, Jaeschke R, Mebazaa A, 
Pinsky MR, Teboul JL, Vincent JL, Rhodes A (2014) Consensus on circulatory shock and 
hemodynamic monitoring. Task force of the European Society of Intensive Care Medi-
cine. Intensive Care Med. 40 (12):1795-1815. doi:10.1007/s00134-014-3525-z
63
Performance of a revised capnodynamic method for cardiac output monitoring
39. Sakka SG, Reuter DA, Perel A (2012) The transpulmonary thermodilution technique. J 
Clin Monit Comput. 26 (5):347-353. doi:10.1007/s10877-012-9378-5
40. Reuter DA, Huang C, Edrich T, Shernan SK, Eltzschig HK (2010) Cardiac output moni-
toring using indicator-dilution techniques: basics, limits, and perspectives. Anesth Analg. 
110 (3):799-811. doi:10.1213/ANE.0b013e3181cc885a
41. Cannesson M, Pestel G, Ricks C, Hoeft A, Perel A (2011) Hemodynamic monitoring and 
management in patients undergoing high risk surgery: a survey among North American 
and European anesthesiologists. Crit Care. 15 (4):R197. doi:10.1186/cc10364
42. Ahmad T, Beilstein CM, Aldecoa C, Moreno RP, Molnar Z, Novak-Jankovic V, Hofer 
CK, Sander M, Rhodes A, Pearse RM (2015) Variation in haemodynamic monitoring for 
major surgery in European nations: secondary analysis of the EuSOS dataset. Perioper 
Med (Lond). 4:8. doi:10.1186/s13741-015-0018-8
43. Renner J, Grunewald M, Bein B (2016) Monitoring high-risk patients: minimally inva-
sive and non-invasive possibilities. Best Pract Res Clin Anaesthesiol. 30 (2):201-216. 
doi:10.1016/j.bpa.2016.04.006
44. Saugel B, Cecconi M, Wagner JY, Reuter DA (2015) Noninvasive continuous cardiac out-
put monitoring in perioperative and intensive care medicine. Br J Anaesth. 114 (4):562-
575. doi:10.1093/bja/aeu447
45. Joosten A, Desebbe O, Suehiro K, Murphy LS, Essiet M, Alexander B, Fischer MO, Barvais 
L, Van Obbergh L, Maucort-Boulch D, Cannesson M (2017) Accuracy and precision of 
non-invasive cardiac output monitoring devices in perioperative medicine: a systematic 
review and meta-analysisdagger. Br J Anaesth. 118 (3):298-310. doi:10.1093/bja/aew461
46. Peyton PJ, Chong SW (2010) Minimally invasive measurement of cardiac output during 
surgery and critical care: a meta-analysis of accuracy and precision. Anesthesiology. 113 
(5):1220-1235. doi:10.1097/ALN.0b013e3181ee3130
47. Yamada T, Vacas S, Gricourt Y, Cannesson M (2018) Improving Perioperative Outcomes 
Through Minimally Invasive and Non-invasive Hemodynamic Monitoring Techniques. 
Front Med (Lausanne). 5:144. doi:10.3389/fmed.2018.00144
48. Thiele RH, Bartels K, Gan TJ (2015) Inter-device differences in monitoring for goal-di-
rected fluid therapy. Can J Anaesth. 62 (2):169-181. doi:10.1007/s12630-014-0265-z
49. Thiele RH, Bartels K, Gan TJ (2015) Cardiac output monitoring: a contemporary assess-
ment and review. Crit Care Med. 43 (1):177-185. doi:10.1097/CCM.0000000000000608
50. Asamoto M, Orii R, Otsuji M, Bougaki M, Imai Y, Yamada Y (2017) Reliability of cardiac 
output measurements using LiDCOrapid and FloTrac/Vigileo across broad ranges of car-
diac output values. J Clin Monit Comput. 31 (4):709-716. doi:10.1007/s10877-016-9896-7
51. Slagt C, Malagon I, Groeneveld AB (2014) Systematic review of uncalibrated arterial pres-
sure waveform analysis to determine cardiac output and stroke volume variation. Br J 
Anaesth. 112 (4):626-637. doi:10.1093/bja/aet429
52. Moonesinghe SR, Mythen MG, Grocott MP (2011) High-risk surgery: epidemiology and 
64
Thorir Sigmundsson
outcomes. Anesth Analg. 112 (4):891-901. doi:10.1213/ANE.0b013e3181e1655b
53. Clement RP, Vos JJ, Scheeren TWL (2017) Minimally invasive cardiac output technolo-
gies in the ICU: putting it all together. Curr Opin Crit Care. 23 (4):302-309. doi:10.1097/
mcc.0000000000000417
54. Ramsingh D, Alexander B, Cannesson M (2013) Clinical review: Does it matter which 
hemodynamic monitoring system is used? Crit Care. 17 (2):208. doi:10.1186/cc11814
55. Gedeon A, Forslund L, Hedenstierna G, Romano E (1980) A new method for noninvasive 
bedside determination of pulmonary blood flow. Med Biol Eng Comput. 18 (4):411-418
56. Capek JM, Roy RJ (1988) Noninvasive measurement of cardiac output using partial CO2 
rebreathing. IEEE Trans Biomed Eng. 35 (9):653-661
57. Peyton PJ (2013) Carbon dioxide elimination and cardiac output changes. Intensive Care 
Med. 39 (5):972. doi:10.1007/s00134-013-2833-z
58. Klein M, Minkovich L, Machina M, Selzner M, Spetzler VN, Knaak JM, Roy D, Duffin J, 
Fisher JA (2015) Non-invasive measurement of cardiac output using an iterative, respira-
tion-based method. Br J Anaesth. 114 (3):406-413. doi:10.1093/bja/aeu377
59. Peyton PJ, Kozub M (2018) Performance of a second generation pulmonary capnotracking 
system for continuous monitoring of cardiac output. J Clin Monit Comput. 32 (6):1057-
1064. doi:10.1007/s10877-018-0110-y
60. Peyton PJ, Robinson GJ, McCall PR, Thompson B (2004) Noninvasive measurement of 
intrapulmonary shunting. J Cardiothorac Vasc Anesth. 18 (1):47-52
61. Albu G, Petak F, Zand T, Hallback M, Wallin M, Habre W (2014) Lung volume assess-
ments in normal and surfactant depleted lungs: agreement between bedside techniques 
and CT imaging. BMC Anesthesiol. 14:64. doi:10.1186/1471-2253-14-64
62. Hallsjo Sander C, Lonnqvist PA, Hallback M, Sipmann FS, Wallin M, Oldner A, Bjorne H 
(2015) Capnodynamic assessment of effective lung volume during cardiac output manip-
ulations in a porcine model. J Clin Monit Comput. doi:10.1007/s10877-015-9767-7
63. Karlsson J (2019) Capnodynamic determination of effective blood flow and end expira-
tory lung volume: studies in children and paediatric animal models. Karolinska Institutet, 
Stockholm
64. Hallsjo Sander C, Hallback M, Wallin M, Emtell P, Oldner A, Bjorne H (2014) Novel 
continuous capnodynamic method for cardiac output assessment during mechanical ven-
tilation. Br J Anaesth. 112 (5):824-831. doi:10.1093/bja/aet486
65. Hallsjo Sander C, Hallback M, Suarez Sipmann F, Wallin M, Oldner A, Bjorne H (2015) 
A novel continuous capnodynamic method for cardiac output assessment in a porcine 
model of lung lavage. Acta Anaesthesiol Scand. doi:10.1111/aas.12559
66. Karlsson J, Winberg P, Scarr B, Lonnqvist PA, Neovius E, Wallin M, Hallback M (2018) 
Validation of capnodynamic determination of cardiac output by measuring effective 
pulmonary blood flow: a study in anaesthetised children and piglets. Br J Anaesth. 121 
(3):550-558. doi:10.1016/j.bja.2018.02.034
65
Performance of a revised capnodynamic method for cardiac output monitoring
67. Karlsson J, Wallin M, Hallback M, Lonnqvist PA (2019) Capnodynamic determination 
of cardiac output in hypoxia-induced pulmonary hypertension in pigs. Br J Anaesth. 122 
(3):335-341. doi:10.1016/j.bja.2018.10.064
68. Saugel B, Grothe O, Wagner JY (2015) Tracking Changes in Cardiac Output: Statistical 
Considerations on the 4-Quadrant Plot and the Polar Plot Methodology. Anesth Analg. 
121 (2):514-524. doi:10.1213/ANE.0000000000000725
69. Cecconi M, Rhodes A, Poloniecki J, Della Rocca G, Grounds RM (2009) Bench-to-bed-
side review: the importance of the precision of the reference technique in method com-
parison studies--with specific reference to the measurement of cardiac output. Critical 
care. 13 (1):201. doi:10.1186/cc7129
70. Bland JM, Altman DG (1986) Statistical methods for assessing agreement between two 
methods of clinical measurement. Lancet. 1 (8476):307-310
71. Hapfelmeier A, Cecconi M, Saugel B (2015) Cardiac output method comparison studies: 
the relation of the precision of agreement and the precision of method. J Clin Monit Com-
put. doi:10.1007/s10877-015-9711-x
72. Critchley LA, Critchley JA (1999) A meta-analysis of studies using bias and precision 
statistics to compare cardiac output measurement techniques. J Clin Monit Comput. 15 
(2):85-91
73. Mackenzie JD, Haites NE, Rawles JM (1986) Method of assessing the reproducibility of 
blood flow measurement: factors influencing the performance of thermodilution cardiac 
output computers. Br Heart J. 55 (1):14-24
74. Bajorat J, Hofmockel R, Vagts DA, Janda M, Pohl B, Beck C, Noeldge-Schomburg G 
(2006) Comparison of invasive and less-invasive techniques of cardiac output measure-
ment under different haemodynamic conditions in a pig model. Eur J Anaesthesiol. 23 
(1):23-30. doi:10.1017/S0265021505001717
75. Botero M, Kirby D, Lobato EB, Staples ED, Gravenstein N (2004) Measurement of cardiac 
output before and after cardiopulmonary bypass: Comparison among aortic transit-time 
ultrasound, thermodilution, and noninvasive partial CO2 rebreathing. J Cardiothorac 
Vasc Anesth. 18 (5):563-572
76. Lamia B, Kim HK, Severyn DA, Pinsky MR (2018) Cross-comparisons of trending 
accuracies of continuous cardiac-output measurements: pulse contour analysis, bioreac-
tance, and pulmonary-artery catheter. J Clin Monit Comput. 32 (1):33-43. doi:10.1007/
s10877-017-9983-4
77. Critchley LA, Lee A, Ho AM (2010) A critical review of the ability of continuous cardiac 
output monitors to measure trends in cardiac output. Anesth Analg. 111 (5):1180-1192. 
doi:10.1213/ANE.0b013e3181f08a5b
78. Critchley LA, Yang XX, Lee A (2011) Assessment of trending ability of cardiac out-
put monitors by polar plot methodology. J Cardiothorac Vasc Anesth. 25 (3):536-546. 
doi:10.1053/j.jvca.2011.01.003
66
Thorir Sigmundsson
79. Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG (2010) Improving biosci-
ence research reporting: The ARRIVE guidelines for reporting animal research. J Phar-
macol Pharmacother. 1 (2):94-99. doi:10.4103/0976-500x.72351
80. World Medical Association Declaration of Helsinki: ethical principles for medical 
research involving human subjects  (2013). JAMA. 310 (20):2191-2194. doi:10.1001/
jama.2013.281053
81. Kottner J, Audige L, Brorson S, Donner A, Gajewski BJ, Hrobjartsson A, Roberts 
C, Shoukri M, Streiner DL (2011) Guidelines for Reporting Reliability and Agree-
ment Studies (GRRAS) were proposed. J Clin Epidemiol. 64 (1):96-106. doi:10.1016/j.
jclinepi.2010.03.002
82. Transonic Systems Inc. Transonic Precision Flowprobes: Perivascular Flowprobe Specifi-
cations. Technical Report (2011). 
83. Dean DA, Jia CX, Cabreriza SE, D’Alessandro DA, Dickstein ML, Sardo MJ, Chalik N, 
Spotnitz HM (1996) Validation study of a new transit time ultrasonic flow probe for con-
tinuous great vessel measurements. ASAIO J. 42 (5):M671-676
84. Giraud R, Siegenthaler N, Merlani P, Bendjelid K (2017) Reproducibility of transpul-
monary thermodilution cardiac output measurements in clinical practice: a systematic 
review. J Clin Monit Comput. 31 (1):43-51. doi:10.1007/s10877-016-9823-y
85. Berggren S (1942) The oxygen deficit of arterial blood caused by non-ventilation parts of 
the lung. Acta Physiol Scand. 4 (Suppl 2):1-92
86. Tusman G, Sipmann FS, Bohm SH (2012) Rationale of dead space measurement by volu-
metric capnography. Anesth Analg. 114 (4):866-874. doi:10.1213/ANE.0b013e318247f6cc
87. Sigmundsson T, Öhman T, Redondo E, Hallbäck M, Wallin M, Suarez Sipmann F, Oldner 
A, Hällsjö Sander C, Björne H (2016) A capnodynamic method for monitoring effective 
pulmonary blood flow - evaluation during hypercapnia. Intensive Care Medicine Experi-
mental. 4 (Suppl 1):A315
88. Monnet X, Persichini R, Ktari M, Jozwiak M, Richard C, Teboul JL (2011) Precision of 
the transpulmonary thermodilution measurements. Crit Care. 15 (4):R204. doi:10.1186/
cc10421
89. Montenij LJ, Buhre WF, Jansen JR, Kruitwagen CL, de Waal EE (2016) Methodology of 
method comparison studies evaluating the validity of cardiac output monitors: a stepwise 
approach and checklist. Br J Anaesth. 116 (6):750-758. doi:10.1093/bja/aew094
90. Lachmann B, Robertson B, Vogel J (1980) In vivo lung lavage as an experimental model 
of the respiratory distress syndrome. Acta Anaesthesiol Scand. 24 (3):231-236
91. Scheer B, Perel A, Pfeiffer UJ (2002) Clinical review: complications and risk factors of 
peripheral arterial catheters used for haemodynamic monitoring in anaesthesia and 
intensive care medicine. Crit Care. 6 (3):199-204
92. Sander CH, Sigmundsson T, Hallback M, Sipmann FS, Wallin M, Oldner A, Bjorne H 
(2016) A modified breathing pattern improves the performance of a continuous capno-
67
Performance of a revised capnodynamic method for cardiac output monitoring
dynamic method for estimation of effective pulmonary blood flow. J Clin Monit Comput. 
doi:10.1007/s10877-016-9891-z
93. Sigmundsson TS, Ohman T, Hallback M, Redondo E, Sipmann FS, Wallin M, Oldner A, 
Hallsjo Sander C, Bjorne H (2018) Performance of a capnodynamic method estimating 
effective pulmonary blood flow during transient and sustained hypercapnia. J Clin Monit 
Comput. 32 (2):311-319. doi:10.1007/s10877-017-0021-3
94. Hedenstierna G, Edmark L (2015) Effects of anesthesia on the respiratory system. Best 
Pract Res Clin Anaesthesiol. 29 (3):273-284. doi:10.1016/j.bpa.2015.08.008
95. Sprung J, Whalley DG, Falcone T, Wilks W, Navratil JE, Bourke DL (2003) The effects 
of tidal volume and respiratory rate on oxygenation and respiratory mechanics during 
laparoscopy in morbidly obese patients. Anesth Analg. 97 (1):268-274, table of contents
96. Talab HF, Zabani IA, Abdelrahman HS, Bukhari WL, Mamoun I, Ashour MA, Sadeq 
BB, El Sayed SI (2009) Intraoperative ventilatory strategies for prevention of pulmonary 
atelectasis in obese patients undergoing laparoscopic bariatric surgery. Anesth Analg. 109 
(5):1511-1516. doi:10.1213/ANE.0b013e3181ba7945
97. Futier E, Constantin JM, Pelosi P, Chanques G, Kwiatkoskwi F, Jaber S, Bazin JE (2010) 
Intraoperative recruitment maneuver reverses detrimental pneumoperitoneum-induced 
respiratory effects in healthy weight and obese patients undergoing laparoscopy. Anesthe-
siology. 113 (6):1310-1319. doi:10.1097/ALN.0b013e3181fc640a
